BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 014778
(419 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 253 bits (646), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 117/127 (92%), Positives = 124/127 (97%)
Query: 251 RKRKPEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT 310
R++KP+DHFFDVPAEEDPEVHLGQLKRFSLRELQVA+DNFSN+NILGRGGFGKVYKGRL
Sbjct: 1 RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 311 DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370
DG+LVAVKRLKEER QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NG
Sbjct: 61 DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 371 SVASCLR 377
SVASCLR
Sbjct: 121 SVASCLR 127
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 238 bits (607), Expect = 5e-63, Method: Compositional matrix adjust.
Identities = 112/119 (94%), Positives = 115/119 (96%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVK 318
FFDVPAEEDPEVHLGQLKRFSLRELQVA+DNF N+NILGRGGFGKVYKGRL DG LVAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 319 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP+M NGSVASCLR
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR 119
>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1
Ectodomain
pdb|3RJ0|A Chain A, Plant Steroid Receptor Bri1 Ectodomain In Complex With
Brassinolide
Length = 772
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 46/89 (51%), Positives = 59/89 (66%)
Query: 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154
LQ L L +N +GK+P L N + LVSL L N L+G IP++LG LSKLR L+L N L
Sbjct: 393 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 452
Query: 155 GEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
GEIP+ L V +L+ L L N LTG+IP+
Sbjct: 453 GEIPQELMYVKTLETLILDFNDLTGEIPS 481
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 39/101 (38%), Positives = 63/101 (62%)
Query: 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154
+ +L++ N +SG +P+E+G++ L L+L N+++G IP +G L L L L++N L
Sbjct: 631 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD 690
Query: 155 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF 195
G IP++++ + L +DLSNN L+G IP G F F P F
Sbjct: 691 GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF 731
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 35/91 (38%), Positives = 58/91 (63%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
+ L+ L+L+ N + G++P+EL + L +L L N+L G IP+ L + L ++ L+NN
Sbjct: 439 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 498
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L GEIP+ + + +L +L LSNN +G+IP
Sbjct: 499 LTGEIPKWIGRLENLAILKLSNNSFSGNIPA 529
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 38/89 (42%), Positives = 51/89 (57%)
Query: 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154
L+ L L N+++G++P L N TNL + L N L G IP +G+L L L+L+NNS
Sbjct: 465 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 524
Query: 155 GEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
G IP L + SL LDL+ N G IP
Sbjct: 525 GNIPAELGDCRSLIWLDLNTNLFNGTIPA 553
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 44/98 (44%), Positives = 62/98 (63%), Gaps = 4/98 (4%)
Query: 95 LQYLELYSNNISGKVPEELGNLT-NLVSLDLYLNNLNGPIPTTLGKLSK--LRFLRLNNN 151
L+ L+L N SG++PE L NL+ +L++LDL NN +GPI L + K L+ L L NN
Sbjct: 342 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 401
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFS 188
G+IP +L+N + L L LS N L+G IP++ GS S
Sbjct: 402 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 439
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 53/89 (59%), Gaps = 3/89 (3%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
NL++L++ SNN S +P LG+ + L LD+ N L+G + ++L+ L +++N
Sbjct: 198 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 256
Query: 154 MGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
+G IP + SLQ L L+ NK TG+IP
Sbjct: 257 VGPIPP--LPLKSLQYLSLAENKFTGEIP 283
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 50/142 (35%), Positives = 75/142 (52%), Gaps = 11/142 (7%)
Query: 45 NVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNA--NXXXXXXXXXXXXTNLQYLELYS 102
N+L W + NPCT+ VTC ++ VT +DL + N S
Sbjct: 25 NLLPDWSSN-KNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 82
Query: 103 N-NISGKVPEELGNLTNLVSLDLYLNNLNGPIPT--TLGKLSKLRFLRLNNNSL--MGEI 157
N +I+G V +L SLDL N+L+GP+ T +LG S L+FL +++N+L G++
Sbjct: 83 NSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKV 141
Query: 158 PRSLTNVNSLQVLDLSNNKLTG 179
L +NSL+VLDLS N ++G
Sbjct: 142 SGGLK-LNSLEVLDLSANSISG 162
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/102 (41%), Positives = 59/102 (57%), Gaps = 5/102 (4%)
Query: 95 LQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
LQYL L N +G++P+ L G L LDL N+ G +P G S L L L++N+
Sbjct: 268 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 327
Query: 154 MGEIP-RSLTNVNSLQVLDLSNNKLTGDIP---TNGSFSLFT 191
GE+P +L + L+VLDLS N+ +G++P TN S SL T
Sbjct: 328 SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLT 369
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 28/76 (36%), Positives = 42/76 (55%)
Query: 107 GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNS 166
G N +++ LD+ N L+G IP +G + L L L +N + G IP + ++
Sbjct: 619 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 678
Query: 167 LQVLDLSNNKLTGDIP 182
L +LDLS+NKL G IP
Sbjct: 679 LNILDLSSNKLDGRIP 694
Score = 49.3 bits (116), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 27/69 (39%), Positives = 41/69 (59%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
TNL ++ L +N ++G++P+ +G L NL L L N+ +G IP LG L +L LN N
Sbjct: 487 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 546
Query: 153 LMGEIPRSL 161
G IP ++
Sbjct: 547 FNGTIPAAM 555
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 22/48 (45%), Positives = 30/48 (62%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLS 141
NL L+L +N+ SG +P ELG+ +L+ LDL N NG IP + K S
Sbjct: 512 NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 559
>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
pdb|3RGZ|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
Length = 768
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 46/89 (51%), Positives = 59/89 (66%)
Query: 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154
LQ L L +N +GK+P L N + LVSL L N L+G IP++LG LSKLR L+L N L
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 155 GEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
GEIP+ L V +L+ L L N LTG+IP+
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPS 484
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 39/101 (38%), Positives = 63/101 (62%)
Query: 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154
+ +L++ N +SG +P+E+G++ L L+L N+++G IP +G L L L L++N L
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD 693
Query: 155 GEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISF 195
G IP++++ + L +DLSNN L+G IP G F F P F
Sbjct: 694 GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF 734
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 35/91 (38%), Positives = 58/91 (63%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
+ L+ L+L+ N + G++P+EL + L +L L N+L G IP+ L + L ++ L+NN
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
L GEIP+ + + +L +L LSNN +G+IP
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 38/89 (42%), Positives = 51/89 (57%)
Query: 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154
L+ L L N+++G++P L N TNL + L N L G IP +G+L L L+L+NNS
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527
Query: 155 GEIPRSLTNVNSLQVLDLSNNKLTGDIPT 183
G IP L + SL LDL+ N G IP
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 44/98 (44%), Positives = 62/98 (63%), Gaps = 4/98 (4%)
Query: 95 LQYLELYSNNISGKVPEELGNLT-NLVSLDLYLNNLNGPIPTTLGKLSK--LRFLRLNNN 151
L+ L+L N SG++PE L NL+ +L++LDL NN +GPI L + K L+ L L NN
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN-GSFS 188
G+IP +L+N + L L LS N L+G IP++ GS S
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 33/89 (37%), Positives = 53/89 (59%), Gaps = 3/89 (3%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
NL++L++ SNN S +P LG+ + L LD+ N L+G + ++L+ L +++N
Sbjct: 201 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
Query: 154 MGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
+G IP + SLQ L L+ NK TG+IP
Sbjct: 260 VGPIPP--LPLKSLQYLSLAENKFTGEIP 286
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 50/142 (35%), Positives = 75/142 (52%), Gaps = 11/142 (7%)
Query: 45 NVLQSWDATLVNPCTWFHVTCNSENSVTRVDLGNA--NXXXXXXXXXXXXTNLQYLELYS 102
N+L W + NPCT+ VTC ++ VT +DL + N S
Sbjct: 28 NLLPDWSSN-KNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 85
Query: 103 N-NISGKVPEELGNLTNLVSLDLYLNNLNGPIPT--TLGKLSKLRFLRLNNNSL--MGEI 157
N +I+G V +L SLDL N+L+GP+ T +LG S L+FL +++N+L G++
Sbjct: 86 NSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKV 144
Query: 158 PRSLTNVNSLQVLDLSNNKLTG 179
L +NSL+VLDLS N ++G
Sbjct: 145 SGGLK-LNSLEVLDLSANSISG 165
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/102 (41%), Positives = 59/102 (57%), Gaps = 5/102 (4%)
Query: 95 LQYLELYSNNISGKVPEEL-GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
LQYL L N +G++P+ L G L LDL N+ G +P G S L L L++N+
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330
Query: 154 MGEIP-RSLTNVNSLQVLDLSNNKLTGDIP---TNGSFSLFT 191
GE+P +L + L+VLDLS N+ +G++P TN S SL T
Sbjct: 331 SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLT 372
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 28/76 (36%), Positives = 42/76 (55%)
Query: 107 GKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNS 166
G N +++ LD+ N L+G IP +G + L L L +N + G IP + ++
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681
Query: 167 LQVLDLSNNKLTGDIP 182
L +LDLS+NKL G IP
Sbjct: 682 LNILDLSSNKLDGRIP 697
Score = 48.9 bits (115), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 27/69 (39%), Positives = 41/69 (59%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
TNL ++ L +N ++G++P+ +G L NL L L N+ +G IP LG L +L LN N
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549
Query: 153 LMGEIPRSL 161
G IP ++
Sbjct: 550 FNGTIPAAM 558
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 22/48 (45%), Positives = 30/48 (62%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLS 141
NL L+L +N+ SG +P ELG+ +L+ LDL N NG IP + K S
Sbjct: 515 NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 562
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 45/102 (44%), Positives = 66/102 (64%), Gaps = 1/102 (0%)
Query: 277 RFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEV 336
R L +L+ AT+NF ++ ++G G FGKVYKG L DG+ VA+KR E +Q G +F+TE+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-GIEEFETEI 86
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
E +S H +L+ L GFC E +L+Y +M NG++ L G
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 45/102 (44%), Positives = 66/102 (64%), Gaps = 1/102 (0%)
Query: 277 RFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEV 336
R L +L+ AT+NF ++ ++G G FGKVYKG L DG+ VA+KR E +Q G +F+TE+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-GIEEFETEI 86
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
E +S H +L+ L GFC E +L+Y +M NG++ L G
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 46/122 (37%), Positives = 66/122 (54%), Gaps = 13/122 (10%)
Query: 269 EVHLGQLKRFSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVKRLK- 321
EV + FS EL+ T+NF R N +G GGFG VYKG + + + VAVK+L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAA 64
Query: 322 --EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV---ASCL 376
+ T+ + QF E+++++ H NL+ L GF + LVY +M NGS+ SCL
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 377 RG 378
G
Sbjct: 125 DG 126
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 46/122 (37%), Positives = 66/122 (54%), Gaps = 13/122 (10%)
Query: 269 EVHLGQLKRFSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVKRLK- 321
EV + FS EL+ T+NF R N +G GGFG VYKG + + + VAVK+L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAA 64
Query: 322 --EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV---ASCL 376
+ T+ + QF E+++++ H NL+ L GF + LVY +M NGS+ SCL
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 377 RG 378
G
Sbjct: 125 DG 126
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 65.5 bits (158), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 44/113 (38%), Positives = 63/113 (55%), Gaps = 13/113 (11%)
Query: 278 FSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVKRLK---EERTQGG 328
FS EL+ T+NF R N +G GGFG VYKG + + + VAVK+L + T+
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 329 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV---ASCLRG 378
+ QF E+++++ H NL+ L GF + LVY +M NGS+ SCL G
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 120
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 43/113 (38%), Positives = 60/113 (53%), Gaps = 13/113 (11%)
Query: 278 FSLRELQVATDNFSNR------NILGRGGFGKVYKGRLTDGSLVAVKRLK---EERTQGG 328
FS EL+ T+NF R N G GGFG VYKG + + + VAVK+L + T+
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 329 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV---ASCLRG 378
+ QF E+++ + H NL+ L GF + LVY + NGS+ SCL G
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDG 117
>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase
Inhibiting Protein), A Leucine Rich Repeat Protein
Involved In Plant Defense
Length = 313
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 35/187 (18%)
Query: 29 EGDALNALKTNLADPNNVLQSWDATLVNPC--TWFHVTCNSENSVTRV---DL------- 76
+ AL +K +L +P L SW T + C TW V C+++ RV DL
Sbjct: 7 DKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 77 --------------------GNANXXXXXXXXXXXXTNLQYLELYSNNISGKVPEELGNL 116
G N T L YL + N+SG +P+ L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 117 TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSL-QVLDLSNN 175
LV+LD N L+G +P ++ L L + + N + G IP S + + L + +S N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 176 KLTGDIP 182
+LTG IP
Sbjct: 185 RLTGKIP 191
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 32/84 (38%), Positives = 48/84 (57%), Gaps = 2/84 (2%)
Query: 98 LELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKL-RFLRLNNNSLMGE 156
L+ N +SG +P + +L NLV + N ++G IP + G SKL + ++ N L G+
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 157 IPRSLTNVNSLQVLDLSNNKLTGD 180
IP + N+N L +DLS N L GD
Sbjct: 190 IPPTFANLN-LAFVDLSRNMLEGD 212
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/122 (30%), Positives = 53/122 (43%), Gaps = 24/122 (19%)
Query: 98 LELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGK------------------ 139
+ + N ++GK+P NL NL +DL N L G G
Sbjct: 179 MTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 140 ----LSK-LRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS 194
LSK L L L NN + G +P+ LT + L L++S N L G+IP G+ F +
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA 297
Query: 195 FA 196
+A
Sbjct: 298 YA 299
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 37/120 (30%), Positives = 57/120 (47%), Gaps = 14/120 (11%)
Query: 294 NILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G G FG+V +GRL S VA+K LK T+ +F +E ++ H N++R
Sbjct: 22 EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
L G +++ FM NG++ S LR G F V G S YL +++V
Sbjct: 82 LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 141
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 296 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ D LVAVK LKE ++ FQ E E+++M H++++R
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVR 84
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR 377
G C L+V+ +M +G + LR
Sbjct: 85 FFGVCTEGRPLLMVFEYMRHGDLNRFLR 112
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 296 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ D LVAVK LKE ++ FQ E E+++M H++++R
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVR 78
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR 377
G C L+V+ +M +G + LR
Sbjct: 79 FFGVCTEGRPLLMVFEYMRHGDLNRFLR 106
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 296 LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
LG G FGKV+ D LVAVK LKE ++ FQ E E+++M H++++R
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVR 107
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR 377
G C L+V+ +M +G + LR
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLR 135
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 37/120 (30%), Positives = 57/120 (47%), Gaps = 14/120 (11%)
Query: 294 NILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G G FG+V +GRL S VA+K LK T+ +F +E ++ H N++R
Sbjct: 20 EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
L G +++ FM NG++ S LR G F V G S YL +++V
Sbjct: 80 LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 139
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 45/155 (29%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL---- 314
F D EDP + + + ++ N S ++G G FG+V GRL S
Sbjct: 22 FVDPHTFEDPTQTVHEFAK------ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 75
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374
VA+K LK T+ F E ++ H N++RL G ++V +M NGS+ S
Sbjct: 76 VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 375 CLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
LR F V G S YL + FV
Sbjct: 136 FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVH 170
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL---- 314
F D EDP + + + ++ N S ++G G FG+V GRL S
Sbjct: 22 FVDPHTYEDPTQTVHEFAK------ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 75
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374
VA+K LK T+ F E ++ H N++RL G ++V +M NGS+ S
Sbjct: 76 VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 375 CLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
LR F V G S YL + +V
Sbjct: 136 FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 48.9 bits (115), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 41 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEAL 100
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 140
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 6/130 (4%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 27 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGMFIVSGFPSFFSYLFFIAF 397
+IS H+N++R G + R ++ M G + S LR PS + L +
Sbjct: 87 IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 398 VQSLIQSLHF 407
+ + +
Sbjct: 147 ARDIACGCQY 156
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 41 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 101 IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 140
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 48.9 bits (115), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 291 SNRNILGRGGFGKVYKGRLTDGS-----LVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ + ++G G FG+VYKG L S VA+K LK T+ + F E ++ H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
N++RL G +++ +M NG++ LR
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLR 138
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL---- 314
F D EDP + + + ++ N S ++G G FG+V GRL S
Sbjct: 22 FVDPHTFEDPTQTVHEFAK------ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 75
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374
VA+K LK T+ F E ++ H N++RL G ++V +M NGS+ S
Sbjct: 76 VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 375 CLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
LR F V G S YL + +V
Sbjct: 136 FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL---- 314
F D EDP + + + ++ N S ++G G FG+V GRL S
Sbjct: 22 FVDPHTFEDPTQTVHEFAK------ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 75
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374
VA+K LK T+ F E ++ H N++RL G ++V +M NGS+ S
Sbjct: 76 VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 375 CLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
LR F V G S YL + +V
Sbjct: 136 FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 43/155 (27%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL---- 314
+ D EDP + + + ++ N S ++G G FG+V GRL S
Sbjct: 22 YVDPHTYEDPTQTVHEFAK------ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 75
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374
VA+K LK T+ F E ++ H N++RL G ++V +M NGS+ S
Sbjct: 76 VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 375 CLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
LR F V G S YL + +V
Sbjct: 136 FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL---- 314
F D EDP + + + ++ N S ++G G FG+V GRL S
Sbjct: 22 FVDPHTFEDPTQTVHEFAK------ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 75
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374
VA+K LK T+ F E ++ H N++RL G ++V +M NGS+ S
Sbjct: 76 VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 375 CLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
LR F V G S YL + +V
Sbjct: 136 FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 41 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 140
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 43/155 (27%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL---- 314
+ D EDP + + + ++ N S ++G G FG+V GRL S
Sbjct: 20 YVDPHTYEDPTQTVHEFAK------ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 73
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374
VA+K LK T+ F E ++ H N++RL G ++V +M NGS+ S
Sbjct: 74 VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 133
Query: 375 CLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
LR F V G S YL + +V
Sbjct: 134 FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 168
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 296 LGRGGFGKVYKGR------LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
+G G FG+V++ R ++VAVK LKEE + + FQ E +++ + N+++
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
L G C L++ +M G + LR M
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSM 144
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 48.5 bits (114), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 125
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 27 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 87 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 126
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 33 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 92
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 93 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 132
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 48.5 bits (114), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 166
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 48.1 bits (113), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 18 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 77
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 78 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 117
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 48.1 bits (113), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 27 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 87 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 126
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 48.1 bits (113), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 43 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 102
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 103 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 142
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 53 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 112
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 113 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 152
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 48.1 bits (113), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLT----DGS--LVAVKRLKEERTQGGELQFQTEVE 337
+V N + LG G FG+VY+G+++ D S VAVK L E ++ EL F E
Sbjct: 44 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 103
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+IS H+N++R G + R ++ M G + S LR
Sbjct: 104 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR 143
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 43/155 (27%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL---- 314
+ D EDP + + + ++ N S ++G G FG+V GRL S
Sbjct: 22 YVDPHTFEDPTQTVHEFAK------ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 75
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374
VA+K LK T+ F E ++ H N++RL G ++V +M NGS+ S
Sbjct: 76 VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 375 CLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
LR F V G S YL + +V
Sbjct: 136 FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 3/101 (2%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEV 336
SL + ++ + + ++ LG G FG+VY+G SL VAVK LKE+ + E F E
Sbjct: 1 MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEA 58
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++ H NL++L G C ++ FM G++ LR
Sbjct: 59 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 99
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 39/125 (31%), Positives = 54/125 (43%), Gaps = 14/125 (11%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVH 344
N S ++G G FG+V GRL S VA+K LK T+ F E ++ H
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR---GMFIV-------SGFPSFFSYLFF 394
N++RL G ++V +M NGS+ S LR F V G S YL
Sbjct: 77 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 136
Query: 395 IAFVQ 399
+ +V
Sbjct: 137 MGYVH 141
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+GRG FG+V+ GRL D +LVAVK +E + +F E ++ H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 355 MTPTERLLVYPFMVNGSVASCLR 377
+V + G + LR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR 204
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 39/125 (31%), Positives = 54/125 (43%), Gaps = 14/125 (11%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVH 344
N S ++G G FG+V GRL S VA+K LK T+ F E ++ H
Sbjct: 34 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR---GMFIV-------SGFPSFFSYLFF 394
N++RL G ++V +M NGS+ S LR F V G S YL
Sbjct: 94 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 153
Query: 395 IAFVQ 399
+ +V
Sbjct: 154 MGYVH 158
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 42/83 (50%), Gaps = 1/83 (1%)
Query: 296 LGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+GRG FG+V+ GRL D +LVAVK +E + +F E ++ H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 355 MTPTERLLVYPFMVNGSVASCLR 377
+V + G + LR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR 204
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVE 337
SL + ++ + + ++ LG G +G+VY+G SL VAVK LKE+ + E F E
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 59
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++ H NL++L G C ++ FM G++ LR
Sbjct: 60 VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR 99
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 34/120 (28%), Positives = 58/120 (48%), Gaps = 5/120 (4%)
Query: 293 RNILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLL 348
++++G G FG+V K R+ L A+KR+KE ++ F E+E++ + H N++
Sbjct: 20 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRGMFIVSGFPSFFSYLFFIAFVQSLIQSLHFA 408
L G C L + +G++ LR ++ P+ F+ A S Q LHFA
Sbjct: 80 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA-FAIANSTASTLSSQQLLHFA 138
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 34/120 (28%), Positives = 58/120 (48%), Gaps = 5/120 (4%)
Query: 293 RNILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLL 348
++++G G FG+V K R+ L A+KR+KE ++ F E+E++ + H N++
Sbjct: 27 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRGMFIVSGFPSFFSYLFFIAFVQSLIQSLHFA 408
L G C L + +G++ LR ++ P+ F+ A S Q LHFA
Sbjct: 87 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA-FAIANSTASTLSSQQLLHFA 145
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 14/142 (9%)
Query: 249 YWRKRKPEDHFFDVP-AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 307
Y++ + PE F+ P E+P G+ R RE++ + + I+G G G+V G
Sbjct: 15 YFQGKLPEPQFYAEPHTYEEP----GRAGRSFTREIEASRIHIEK--IIGSGDSGEVCYG 68
Query: 308 RL----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363
RL VA+K LK T+ F +E ++ H N++RL G ++V
Sbjct: 69 RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128
Query: 364 YPFMVNGSVASCLR---GMFIV 382
+M NGS+ + LR G F +
Sbjct: 129 TEYMENGSLDTFLRTHDGQFTI 150
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 34/120 (28%), Positives = 58/120 (48%), Gaps = 5/120 (4%)
Query: 293 RNILGRGGFGKVYKGRLTDGSL---VAVKRLKEERTQGGELQFQTEVEMI-SMAVHRNLL 348
++++G G FG+V K R+ L A+KR+KE ++ F E+E++ + H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLRGMFIVSGFPSFFSYLFFIAFVQSLIQSLHFA 408
L G C L + +G++ LR ++ P+ F+ A S Q LHFA
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA-FAIANSTASTLSSQQLLHFA 148
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 14/142 (9%)
Query: 249 YWRKRKPEDHFFDVP-AEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKG 307
Y++ + PE F+ P E+P G+ R RE++ + + I+G G G+V G
Sbjct: 15 YFQGKLPEPQFYAEPHTYEEP----GRAGRSFTREIEASRIHIEK--IIGSGDSGEVCYG 68
Query: 308 RL----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 363
RL VA+K LK T+ F +E ++ H N++RL G ++V
Sbjct: 69 RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128
Query: 364 YPFMVNGSVASCLR---GMFIV 382
+M NGS+ + LR G F +
Sbjct: 129 TEYMENGSLDTFLRTHDGQFTI 150
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 17/118 (14%)
Query: 285 VATDNFSNRNI-----LGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQGGELQFQ 333
+ + R+I LG G FGKV+ D LVAVK LK+ T FQ
Sbjct: 7 IHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQ 65
Query: 334 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR-----GMFIVSGFP 386
E E+++ H ++++ G C ++V+ +M +G + LR M +V G P
Sbjct: 66 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/155 (27%), Positives = 63/155 (40%), Gaps = 20/155 (12%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL---- 314
+ D EDP + + + ++ N S ++G G FG+V GRL S
Sbjct: 22 YVDPHTYEDPTQTVHEFAK------ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 75
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374
VA+K LK T+ F E ++ H N++RL G ++V M NGS+ S
Sbjct: 76 VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 375 CLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
LR F V G S YL + +V
Sbjct: 136 FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 37/123 (30%), Positives = 54/123 (43%), Gaps = 10/123 (8%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL---- 314
F D EDP + + + ++ N S ++G G FG+V GRL S
Sbjct: 22 FVDPHTFEDPTQTVHEFAK------ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS 75
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374
VA+K LK T+ F E ++ H N++RL G ++V M NGS+ S
Sbjct: 76 VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 375 CLR 377
LR
Sbjct: 136 FLR 138
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 3/101 (2%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEV 336
SL + ++ + + ++ LG G +G+VY+G SL VAVK LKE+ + E F E
Sbjct: 1 MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEA 58
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++ H NL++L G C ++ FM G++ LR
Sbjct: 59 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 99
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 293 RNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
++G G FG+V G L VA+K LK T+ F +E ++ H N++
Sbjct: 38 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR---GMFIV 382
L G T +++ FM NGS+ S LR G F V
Sbjct: 98 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 134
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 39/125 (31%), Positives = 53/125 (42%), Gaps = 14/125 (11%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMISMAVH 344
N S ++G G FG+V GRL S VA+K LK T+ F E ++ H
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR---GMFIV-------SGFPSFFSYLFF 394
N++RL G ++V M NGS+ S LR F V G S YL
Sbjct: 77 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 136
Query: 395 IAFVQ 399
+ +V
Sbjct: 137 MGYVH 141
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 293 RNILGRGGFGKVYKGRLT----DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
++G G FG+V G L VA+K LK T+ F +E ++ H N++
Sbjct: 12 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR---GMFIV 382
L G T +++ FM NGS+ S LR G F V
Sbjct: 72 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV 108
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 6/103 (5%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLK----EERTQGGELQFQTEVEM 338
L++ + I+G GGFGKVY+ G VAVK + E+ +Q E + E ++
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIE-NVRQEAKL 59
Query: 339 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGMFI 381
+M H N++ LRG C+ LV F G + L G I
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI 102
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 75 IVRLRYFFYSSGEK 88
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 22 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 75
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 76 IVRLRYFFYSSGEK 89
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 75 IVRLRYFFYSSGEK 88
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 75 IVRLRYFFYSSGEK 88
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 26 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 79
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 80 IVRLRYFFYSSGEK 93
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 19 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 76
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 77 VQLLGVCTREPPFYIIIEFMTYGNLLDYLR 106
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 34 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 87
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 88 IVRLRYFFYSSGEK 101
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 75 IVRLRYFFYSSGEK 88
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 40 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 93
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 94 IVRLRYFFYSSGEK 107
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 29 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 82
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 83 IVRLRYFFYSSGEK 96
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 87 IVRLRYFFYSSGEK 100
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 19 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 76
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 77 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 106
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 25 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 78
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 79 IVRLRYFFYSSGEK 92
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 49 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 102
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 103 IVRLRYFFYSSGEK 116
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 15 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 72
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 73 VQLLGVCTREPPFYIIIEFMTYGNLLDYLR 102
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 45.1 bits (105), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 87 IVRLRYFFYSSGEK 100
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 45.1 bits (105), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 71
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 72 VQLLGVCTREPPFYIIIEFMTYGNLLDYLR 101
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 45.1 bits (105), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 71
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 101
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 75
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 105
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 19 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 76
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 77 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 106
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 71
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 101
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 16 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 73
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 74 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 103
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 16 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 73
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 74 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 103
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 108
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 109 IVRLRYFFYSSGEK 122
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 27 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 84
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 85 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 114
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 15 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 72
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 73 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 102
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 16 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 73
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 74 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 103
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 71
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 101
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 24/67 (35%), Positives = 43/67 (64%), Gaps = 8/67 (11%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 108
Query: 347 LLRLRGF 353
++RLR F
Sbjct: 109 IVRLRYF 115
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/119 (31%), Positives = 58/119 (48%), Gaps = 4/119 (3%)
Query: 265 EEDPEVHLG-QLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKE 322
E +PE L + K ++ Q A ++F LG+G FG VY R + A+K L +
Sbjct: 10 ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 69
Query: 323 ERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ + G E Q + EVE+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 70 AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 128
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 19 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 76
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 77 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 106
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/119 (31%), Positives = 58/119 (48%), Gaps = 4/119 (3%)
Query: 265 EEDPEVHLG-QLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKE 322
E +PE L + K ++ Q A ++F LG+G FG VY R + A+K L +
Sbjct: 10 ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 69
Query: 323 ERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ + G E Q + EVE+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 70 AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 128
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/119 (31%), Positives = 58/119 (48%), Gaps = 4/119 (3%)
Query: 265 EEDPEVHLG-QLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKE 322
E +PE L + K ++ Q A ++F LG+G FG VY R + A+K L +
Sbjct: 1 ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 60
Query: 323 ERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ + G E Q + EVE+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 61 AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 119
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 57 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 110
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 111 IVRLRYFFYSSGEK 124
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 71
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 72 VQLLGVCTREPPFYIIIEFMTYGNLLDYLR 101
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 59 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 112
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 113 IVRLRYFFYSSGEK 126
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 41 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 129
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 34 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 94 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 122
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 25/74 (33%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K+ L+++R + ELQ +++ H N
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 153
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 154 IVRLRYFFYSSGEK 167
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 19 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 76
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 77 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 106
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 3/90 (3%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+ + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++ H NL
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNL 71
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L G C ++ FM G++ LR
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLR 101
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G V L+ +
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL 107
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMA 342
++ + + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEI 273
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H NL++L G C ++ FM G++ LR
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 308
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 37 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 97 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 125
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 5/74 (6%)
Query: 294 NILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
+LG G FG VYKG + +G V A+K L E ++F E +++ H +L+
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 349 RLRGFCMTPTERLL 362
RL G C++PT +L+
Sbjct: 81 RLLGVCLSPTIQLV 94
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 7/87 (8%)
Query: 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRL----KEERTQGGE--LQFQTEVE 337
+A + +G+GGFG V+KGRL D S+VA+K L E T+ E +FQ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVY 364
++S H N+++L G P ++ +
Sbjct: 76 IMSNLNHPNIVKLYGLMHNPPRMVMEF 102
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 183
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 55 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 143
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 37 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 97 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 125
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 54 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 142
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G V L+ +
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL 107
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 35 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 95 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 123
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 7/87 (8%)
Query: 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRL----KEERTQGGE--LQFQTEVE 337
+A + +G+GGFG V+KGRL D S+VA+K L E T+ E +FQ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVY 364
++S H N+++L G P ++ +
Sbjct: 76 IMSNLNHPNIVKLYGLMHNPPRMVMEF 102
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 124
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 7/87 (8%)
Query: 285 VATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRL----KEERTQGGE--LQFQTEVE 337
+A + +G+GGFG V+KGRL D S+VA+K L E T+ E +FQ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVY 364
++S H N+++L G P ++ +
Sbjct: 76 IMSNLNHPNIVKLYGLMHNPPRMVMEF 102
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 49/104 (47%), Gaps = 3/104 (2%)
Query: 280 LRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEM 338
L+E + + ++G+G FG+VY GR VA++ + ER +L+ F+ EV
Sbjct: 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 339 ISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGMFIV 382
H N++ G CM+P ++ ++ S +R IV
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV 126
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 119
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMA 342
++ + + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++
Sbjct: 255 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEI 312
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H NL++L G C ++ FM G++ LR
Sbjct: 313 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 347
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMISMA 342
++ + + ++ LG G +G+VY+G SL VAVK LKE+ + E F E ++
Sbjct: 213 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEI 270
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H NL++L G C ++ FM G++ LR
Sbjct: 271 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 305
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 28 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 88 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 116
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 34 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 94 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 122
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 294 NILGRGGFGKVYKGRL--TDGSLV--AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++GRG FG VY G L DG + AVK L G QF TE ++ H N+L
Sbjct: 35 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 350 LRGFCM-TPTERLLVYPFMVNGSVASCLR 377
L G C+ + L+V P+M +G + + +R
Sbjct: 95 LLGICLRSEGSPLVVLPYMKHGDLRNFIR 123
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 3/100 (3%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVE 337
S+ + ++ + + ++ LG G +G+VY G SL VAVK LKE+ + E F E
Sbjct: 23 SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 80
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++ H NL++L G C +V +M G++ LR
Sbjct: 81 VMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLR 120
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 5/74 (6%)
Query: 294 NILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
+LG G FG VYKG + +G V A+K L E ++F E +++ H +L+
Sbjct: 44 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 349 RLRGFCMTPTERLL 362
RL G C++PT +L+
Sbjct: 104 RLLGVCLSPTIQLV 117
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + + A+K L + + + G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 64 HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKL 102
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 103
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 103
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 1 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 61 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G G FG V+ G + VA+K +KE E F E E++ H L++L G C+
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS--EDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 356 TPTERLLVYPFMVNGSVASCLR 377
LV+ FM +G ++ LR
Sbjct: 93 EQAPICLVFEFMEHGCLSDYLR 114
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 103
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 7 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 3 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 63 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 101
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 107
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 3 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 63 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 104
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 3 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 63 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 104
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 13/106 (12%)
Query: 273 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQF 332
G L +E++V ++GRG FG V K + VA+K+++ E + F
Sbjct: 1 GSLHMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAKD-VAIKQIESESERKA---F 49
Query: 333 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
E+ +S H N+++L G C+ P LV + GS+ + L G
Sbjct: 50 IVELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHG 93
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 107
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 6 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 66 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 107
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVE 337
++ Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE
Sbjct: 4 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
+ S H N+LRL G+ T L+ + G+V L+ +
Sbjct: 64 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 102
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 8 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 68 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 106
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 7 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 105
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q A ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 1 QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 61 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 99
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G G FG V+ G + VA+K ++E E F E E++ H L++L G C+
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 356 TPTERLLVYPFMVNGSVASCLR 377
LV+ FM +G ++ LR
Sbjct: 73 EQAPICLVFEFMEHGCLSDYLR 94
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 42.4 bits (98), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G G FG V+ G + VA+K ++E E F E E++ H L++L G C+
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 356 TPTERLLVYPFMVNGSVASCLR 377
LV+ FM +G ++ LR
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLR 92
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G G FG V+ G + VA+K ++E E F E E++ H L++L G C+
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 356 TPTERLLVYPFMVNGSVASCLR 377
LV+ FM +G ++ LR
Sbjct: 73 EQAPICLVFEFMEHGCLSDYLR 94
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G G FG V+ G + VA+K ++E E F E E++ H L++L G C+
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 356 TPTERLLVYPFMVNGSVASCLR 377
LV+ FM +G ++ LR
Sbjct: 76 EQAPICLVFEFMEHGCLSDYLR 97
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 34/120 (28%), Positives = 52/120 (43%), Gaps = 14/120 (11%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G G FG+V GRL VA+K LK T F +E ++ H N++
Sbjct: 20 KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
L G +++ +M NGS+ + LR G F V G S YL +++V
Sbjct: 80 LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 139
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 41.6 bits (96), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 41/155 (26%), Positives = 62/155 (40%), Gaps = 20/155 (12%)
Query: 259 FFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT----DGSL 314
+ D EDP + Q + EL + ++G G FG+V GRL
Sbjct: 20 YIDPETYEDPNRAVHQFAK----ELDASC--IKIERVIGAGEFGEVCSGRLKLPGKRDVA 73
Query: 315 VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVAS 374
VA+K LK T+ F E ++ H N++ L G ++V FM NG++ +
Sbjct: 74 VAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDA 133
Query: 375 CLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
LR G F V G + YL + +V
Sbjct: 134 FLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVH 168
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 41.6 bits (96), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 34/120 (28%), Positives = 52/120 (43%), Gaps = 14/120 (11%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G G FG+V GRL VA+K LK T F +E ++ H N++
Sbjct: 14 KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR---GMFIV-------SGFPSFFSYLFFIAFVQ 399
L G +++ +M NGS+ + LR G F V G S YL +++V
Sbjct: 74 LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 133
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 40/85 (47%), Gaps = 1/85 (1%)
Query: 286 ATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 344
++ F LG G + VYKG T G VA+K +K + +G E+ ++ H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVN 369
N++RL T + LV+ FM N
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDN 87
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 6/86 (6%)
Query: 293 RNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
++GRG FG V K + VA+K+++ E + F E+ +S H N+++L G
Sbjct: 13 EEVVGRGAFGVVCKAKWRAKD-VAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYG 68
Query: 353 FCMTPTERLLVYPFMVNGSVASCLRG 378
C+ P LV + GS+ + L G
Sbjct: 69 ACLNPV--CLVMEYAEGGSLYNVLHG 92
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 8/74 (10%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRN 346
++++ ++G G FG VY+ +L D G LVA+K++ + + + ELQ +++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLD------HCN 74
Query: 347 LLRLRGFCMTPTER 360
++RLR F + E+
Sbjct: 75 IVRLRYFFYSSGEK 88
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/73 (31%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
++++ ++G G FG VY+ +L D G LVA+K++ QG + E++++ H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFK-NRELQIMRKLDHCNI 75
Query: 348 LRLRGFCMTPTER 360
+RLR F + E+
Sbjct: 76 VRLRYFFYSSGEK 88
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/73 (31%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 289 NFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
++++ ++G G FG VY+ +L D G LVA+K++ QG + E++++ H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFK-NRELQIMRKLDHCNI 75
Query: 348 LRLRGFCMTPTER 360
+RLR F + E+
Sbjct: 76 VRLRYFFYSSGEK 88
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 8 QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 68 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 106
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 3/99 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRLKEERTQ--GGELQFQTEVEMIS 340
Q ++F LG+G FG VY R + A+K L + + + G E Q + EVE+ S
Sbjct: 8 QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
H N+LRL G+ T L+ + G+V L+ +
Sbjct: 68 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 106
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ F+ GS+ L+
Sbjct: 80 KGVCYSAGRRNLKLIMEFLPYGSLREYLQ 108
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
+G G FG V+ G + VA+K ++E E F E E++ H L++L G C+
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 356 TPTERLLVYPFMVNGSVASCLR 377
LV FM +G ++ LR
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLR 95
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLRG 378
+G C + R L+ ++ GS+ L+
Sbjct: 80 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQA 109
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 2/84 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 356 TPTERLLVYPFMVNGSVASCLRGM 379
++ +M NG + + LR M
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREM 93
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 39/130 (30%), Positives = 60/130 (46%), Gaps = 18/130 (13%)
Query: 285 VATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISM 341
V +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 4 VDMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAF 397
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 63 LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF---- 114
Query: 398 VQSLIQSLHF 407
L+Q L F
Sbjct: 115 --QLLQGLAF 122
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 7/96 (7%)
Query: 294 NILGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 349
++G G FG+V GRL VA+K LK T F +E ++ H N++
Sbjct: 35 KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 350 LRGFCMTPTERLLVYPFMVNGSVASCLR---GMFIV 382
L G +++ +M NGS+ + LR G F V
Sbjct: 95 LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV 130
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 2/84 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 356 TPTERLLVYPFMVNGSVASCLRGM 379
++ +M NG + + LR M
Sbjct: 74 KQRPIFIITEYMANGCLLNYLREM 97
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 2/84 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 356 TPTERLLVYPFMVNGSVASCLRGM 379
++ +M NG + + LR M
Sbjct: 75 KQRPIFIITEYMANGCLLNYLREM 98
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 2/84 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 356 TPTERLLVYPFMVNGSVASCLRGM 379
++ +M NG + + LR M
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREM 113
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 2/84 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 356 TPTERLLVYPFMVNGSVASCLRGM 379
++ +M NG + + LR M
Sbjct: 75 KQRPIFIITEYMANGCLLNYLREM 98
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 10/93 (10%)
Query: 294 NILGRGGFGKVYKGRLT--DGS--LVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLL 348
ILG G FG V +G L DG+ VAVK +K + + E++ F +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 349 RLRGFCMTPTER-----LLVYPFMVNGSVASCL 376
RL G C+ + + +++ PFM G + + L
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 2/84 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 356 TPTERLLVYPFMVNGSVASCLRGM 379
++ +M NG + + LR M
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREM 113
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 105
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 19 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 78 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 106
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 24 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 83 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 111
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 2/84 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V G+ VA+K +KE E +F E +++ H L++L G C
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 356 TPTERLLVYPFMVNGSVASCLRGM 379
++ +M NG + + LR M
Sbjct: 81 KQRPIFIITEYMANGCLLNYLREM 104
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 23 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 82 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 110
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 344 HRNLLRLRGFCMTPTERLLV 363
+ ++ RL G C+T T +L++
Sbjct: 80 NPHVCRLLGICLTSTVQLIM 99
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 25 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 84 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 112
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 17 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 76 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 104
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 344 HRNLLRLRGFCMTPTERLLV 363
+ ++ RL G C+T T +L++
Sbjct: 77 NPHVCRLLGICLTSTVQLIM 96
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/148 (25%), Positives = 61/148 (41%), Gaps = 20/148 (13%)
Query: 266 EDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLT-DGSL---VAVKRLK 321
EDP + + + ++ + ++G G FG+V GRL G VA+K LK
Sbjct: 6 EDPNQAVHEFAK------EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLK 59
Query: 322 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR---G 378
T+ F E ++ H N++ L G ++V +M NGS+ + L+ G
Sbjct: 60 VGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG 119
Query: 379 MFIV-------SGFPSFFSYLFFIAFVQ 399
F V G + YL + +V
Sbjct: 120 QFTVIQLVGMLRGISAGMKYLSDMGYVH 147
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 22 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 81 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 109
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 105
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 105
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 80 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 108
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 344 HRNLLRLRGFCMTPTERLLV 363
+ ++ RL G C+T T +L++
Sbjct: 77 NPHVCRLLGICLTSTVQLIM 96
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L + T+ F+ E+E++ H N+++
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 75 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 103
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 344 HRNLLRLRGFCMTPTERLLV 363
+ ++ RL G C+T T +L++
Sbjct: 78 NPHVCRLLGICLTSTVQLIM 97
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 344 HRNLLRLRGFCMTPTERLLV 363
+ ++ RL G C+T T +L++
Sbjct: 80 NPHVCRLLGICLTSTVQLIM 99
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 344 HRNLLRLRGFCMTPTERLLV 363
+ ++ RL G C+T T +L++
Sbjct: 79 NPHVCRLLGICLTSTVQLIM 98
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 344 HRNLLRLRGFCMTPTERLLV 363
+ ++ RL G C+T T +L++
Sbjct: 76 NPHVCRLLGICLTSTVQLIM 95
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRA 134
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 110
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 111 -QLLQGLAF 118
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPF 94
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGI----PLPLIKSYLF----- 110
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 111 -QLLQGLAF 118
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 123
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 110
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 111 -QLLQGLAF 118
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 344 HRNLLRLRGFCMTPTERLLV 363
+ ++ RL G C+T T +L++
Sbjct: 78 NPHVCRLLGICLTSTVQLIM 97
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 13 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 73 NPHVCRLLGICLTSTVQLITQLMPF 97
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 76 NPHVCRLLGICLTSTVQLITQLMPF 100
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 79 NPHVCRLLGICLTSTVQLITQLMPF 103
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 111
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 112 LLQGLSF 118
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 22 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 82 NPHVCRLLGICLTSTVQLITQLMPF 106
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 79 NPHVCRLLGICLTSTVQLITQLMPF 103
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 24/79 (30%), Positives = 40/79 (50%), Gaps = 5/79 (6%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 41 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 344 HRNLLRLRGFCMTPTERLL 362
+ ++ RL G C+T T +L+
Sbjct: 101 NPHVCRLLGICLTSTVQLI 119
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 110
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 111 -QLLQGLAF 118
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 78 NPHVCRLLGICLTSTVQLITQLMPF 102
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 110
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 111 LLQGLAF 117
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYKGR---LTD--GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG+G FG V R L D G +VAVK+L+ T+ F+ E+E++ H N+++
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 351 RGFCMTPTER--LLVYPFMVNGSVASCLR 377
+G C + R L+ ++ GS+ L+
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 123
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 3/90 (3%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERT-QGGELQF-QTEVEMIS 340
++ DNF +LG+G FGKV R+ + G L AVK LK++ Q +++ TE ++S
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNG 370
+A + L C +RL VNG
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNG 108
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 76 NPHVCRLLGICLTSTVQLITQLMPF 100
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMV----NGSVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ + AS L G+ P SYLF
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGI----PLPLIKSYLF----- 113
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 114 -QLLQGLAF 121
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 110
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 111 LLQGLAF 117
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 110
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 111 LLQGLAF 117
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 344 HRNLLRLRGFCMTPTERLLV 363
+ ++ RL G C+T T +L++
Sbjct: 78 NPHVCRLLGICLTSTVQLIM 97
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 111
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 112 LLQGLAF 118
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 111
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 112 LLQGLAF 118
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 26 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 86 NPHVCRLLGICLTSTVQLITQLMPF 110
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 110
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 111 LLQGLAF 117
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 62 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 112
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 113 -QLLQGLAF 120
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 23 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 83 NPHVCRLLGICLTSTVQLITQLMPF 107
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 110
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 111 -QLLQGLAF 118
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 76 NPHVCRLLGICLTSTVQLITQLMPF 100
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 76 NPHVCRLLGICLTSTVQLITQLMPF 100
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 63 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 112
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 113 LLQGLAF 119
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 61 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 111
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 112 -QLLQGLAF 119
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 62 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 112
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 113 -QLLQGLAF 120
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 113
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 114 -QLLQGLAF 121
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 62 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 112
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 113 -QLLQGLAF 120
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQ 331
F E +V+ + + LG+G FG VY+G D + VAVK + E + ++
Sbjct: 7 FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 332 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
F E ++ +++RL G L+V M +G + S LR +
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMV----NGSVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ + AS L G+ P SYLF
Sbjct: 62 NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGI----PLPLIKSYLF----- 112
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 113 -QLLQGLAF 120
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 79 NPHVCRLLGICLTSTVQLITQLMPF 103
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQ 331
F E +V+ + + LG+G FG VY+G D + VAVK + E + ++
Sbjct: 7 FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 332 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
F E ++ +++RL G L+V M +G + S LR +
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 61 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 111
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 112 -QLLQGLAF 119
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 61 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 111
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 112 -QLLQGLAF 119
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGI----PLPLIKSYLF----- 113
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 114 -QLLQGLAF 121
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 23 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 83 NPHVCRLLGICLTSTVQLITQLMPF 107
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQ 331
F E +V+ + + LG+G FG VY+G D + VAVK + E + ++
Sbjct: 7 FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 332 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
F E ++ +++RL G L+V M +G + S LR +
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTE 335
E +V+ + + LG+G FG VY+G D + VAVK + E + ++F E
Sbjct: 11 EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L+V M +G + S LR +
Sbjct: 71 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 111
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 112 LLQGLAF 118
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 64 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 114
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 115 -QLLQGLAF 122
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 69 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 118
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 119 LLQGLAF 125
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF----- 113
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 114 -QLLQGLAF 121
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 78 NPHVCRLLGICLTSTVQLITQLMPF 102
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQ 331
F E +V+ + + LG+G FG VY+G D + VAVK + E + ++
Sbjct: 4 FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 63
Query: 332 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
F E ++ +++RL G L+V M +G + S LR +
Sbjct: 64 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 111
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTE 335
E +V+ + + LG+G FG VY+G D + VAVK + E + ++F E
Sbjct: 11 EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L+V M +G + S LR +
Sbjct: 71 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 114
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTE 335
E +V+ + + LG+G FG VY+G D + VAVK + E + ++F E
Sbjct: 12 EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 71
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L+V M +G + S LR +
Sbjct: 72 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 115
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 38/127 (29%), Positives = 59/127 (46%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 69 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 118
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 119 LLQGLAF 125
>pdb|3A79|A Chain A, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex
pdb|3A7B|A Chain A, Crystal Structure Of Tlr2-Streptococcus Pneumoniae
Lipoteichoic Acid Complex
pdb|3A7C|A Chain A, Crystal Structure Of Tlr2-Pe-Dtpa Complex
Length = 580
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 38/104 (36%), Positives = 53/104 (50%), Gaps = 19/104 (18%)
Query: 94 NLQYLELYSNNISG--KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+LQ L L N++ K E L L NL SLD+ N + P+P + K+RFL L++
Sbjct: 388 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST 446
Query: 152 SL---MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP 192
+ IP++L +VLD+SNN L SFSLF P
Sbjct: 447 GIRVVKTCIPQTL------EVLDVSNNNL-------DSFSLFLP 477
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRA 134
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGI----PLPLIKSYLF----- 113
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 114 -QLLQGLAF 121
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 61 NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGI----PLPLIKSYLF----- 111
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 112 -QLLQGLAF 119
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 33/122 (27%), Positives = 57/122 (46%), Gaps = 8/122 (6%)
Query: 296 LGRGGFGKV--YKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
LG GGF V +G L DG A+KR+ Q E + Q E +M + H N+LRL +
Sbjct: 37 LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNILRLVAY 94
Query: 354 CM----TPTERLLVYPFMVNGSVASCLRGMFIVSGFPSFFSYLFFIAFVQSLIQSLHFAK 409
C+ E L+ PF G++ + + + F + L+ + + ++++H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 410 YS 411
Y+
Sbjct: 155 YA 156
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 18/81 (22%), Positives = 42/81 (51%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FGKVYK + + S++A ++ + +++ + E+++++ H N+++L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 356 TPTERLLVYPFMVNGSVASCL 376
++ F G+V + +
Sbjct: 105 YENNLWILIEFCAGGAVDAVM 125
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 30 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 90 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 121
>pdb|2Z81|A Chain A, Crystal Structure Of The Tlr1-tlr2 Heterodimer Induced By
Binding Of A Tri-acylated Lipopeptide
pdb|2Z82|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 549
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 38/104 (36%), Positives = 53/104 (50%), Gaps = 19/104 (18%)
Query: 94 NLQYLELYSNNISG--KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+LQ L L N++ K E L L NL SLD+ N + P+P + K+RFL L++
Sbjct: 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST 420
Query: 152 SL---MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTP 192
+ IP++L +VLD+SNN L SFSLF P
Sbjct: 421 GIRVVKTCIPQTL------EVLDVSNNNL-------DSFSLFLP 451
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 18/81 (22%), Positives = 42/81 (51%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FGKVYK + + S++A ++ + +++ + E+++++ H N+++L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 356 TPTERLLVYPFMVNGSVASCL 376
++ F G+V + +
Sbjct: 105 YENNLWILIEFCAGGAVDAVM 125
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 19/65 (29%), Positives = 39/65 (60%), Gaps = 7/65 (10%)
Query: 290 FSNRNILGRGGFGKVYKGRLTDGSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLL 348
++N ++G G FG V++ +L + VA+K+ L+++R + ELQ ++ + H N++
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ------IMRIVKHPNVV 95
Query: 349 RLRGF 353
L+ F
Sbjct: 96 DLKAF 100
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 18/81 (22%), Positives = 42/81 (51%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FGKVYK + + S++A ++ + +++ + E+++++ H N+++L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 356 TPTERLLVYPFMVNGSVASCL 376
++ F G+V + +
Sbjct: 105 YENNLWILIEFCAGGAVDAVM 125
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 35 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 95 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 126
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 32 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 92 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 123
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 41/82 (50%), Gaps = 3/82 (3%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 345
+ + + LG G + VYKG+ LTD +LVA+K ++ E +G EV ++ H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 346 NLLRLRGFCMTPTERLLVYPFM 367
N++ L T LV+ ++
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYL 82
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK++ T+ +E+EM+ M H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ LR
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRA 180
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 18/45 (40%), Positives = 29/45 (64%), Gaps = 1/45 (2%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQ 326
+ + ++FS I+GRGGFG+VY R D G + A+K L ++R +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK 228
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 18/45 (40%), Positives = 29/45 (64%), Gaps = 1/45 (2%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQ 326
+ + ++FS I+GRGGFG+VY R D G + A+K L ++R +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK 228
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 18/45 (40%), Positives = 29/45 (64%), Gaps = 1/45 (2%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQ 326
+ + ++FS I+GRGGFG+VY R D G + A+K L ++R +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK 228
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 18/45 (40%), Positives = 29/45 (64%), Gaps = 1/45 (2%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQ 326
+ + ++FS I+GRGGFG+VY R D G + A+K L ++R +
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK 227
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVY----KGRLTD--GSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 41 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L++ M G + S LR +
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 144
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVY----KGRLTD--GSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L++ M G + S LR +
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 122
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVY----KGRLTD--GSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 12 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L++ M G + S LR +
Sbjct: 72 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 115
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 37.4 bits (85), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 278 FSLRELQVATDNFSNRNILGRGGFGKVY----KGRLTD--GSLVAVKRLKEERTQGGELQ 331
F E +VA + + LG+G FG VY KG + D + VA+K + E + ++
Sbjct: 6 FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 332 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
F E ++ +++RL G L++ M G + S LR +
Sbjct: 66 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 113
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 37.4 bits (85), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 26/104 (25%), Positives = 47/104 (45%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY+G + + VA+K + E + ++F E
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L++ M G + S LR +
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 122
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 37.4 bits (85), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 7/97 (7%)
Query: 288 DNFSNRNILGRGGFGKV-----YKGRLTDGSL-VAVKRLKEERTQGGELQFQTEVEMIS- 340
+N +LG G FGKV Y T S+ VAVK LKE+ +E++M++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+ H N++ L G C L++ + G + + LR
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 141
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVY----KGRLTD--GSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 12 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L++ M G + S LR +
Sbjct: 72 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 115
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +L G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 16 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 76 NPHVCRLLGICLTSTVQLITQLMPF 100
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVY----KGRLTD--GSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 9 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L++ M G + S LR +
Sbjct: 69 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 112
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 37/127 (29%), Positives = 58/127 (45%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+ +++ + T+G E+ ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 111
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 112 LLQGLAF 118
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 37/127 (29%), Positives = 58/127 (45%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+ +++ + T+G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ F+ AS L G+ P SYLF
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI----PLPLIKSYLF------Q 110
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 111 LLQGLAF 117
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVY----KGRLTD--GSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 13 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L++ M G + S LR +
Sbjct: 73 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 116
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 37.0 bits (84), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVY----KGRLTD--GSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L++ M G + S LR +
Sbjct: 66 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 109
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 40/80 (50%), Gaps = 5/80 (6%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +L G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 23 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 344 HRNLLRLRGFCMTPTERLLV 363
+ ++ RL G C+T T +L++
Sbjct: 83 NPHVCRLLGICLTSTVQLIM 102
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVY----KGRLTD--GSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 13 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L++ M G + S LR +
Sbjct: 73 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 116
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 124
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVY----KGRLTD--GSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 4 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L++ M G + S LR +
Sbjct: 64 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 107
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVY----KGRLTD--GSLVAVKRLKEERTQGGELQFQTE 335
E +VA + + LG+G FG VY KG + D + VA+K + E + ++F E
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 336 VEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L++ M G + S LR +
Sbjct: 66 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 109
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 37.0 bits (84), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 124
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 37.0 bits (84), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 27/102 (26%), Positives = 47/102 (46%), Gaps = 6/102 (5%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTD------GSLVAVKRLKEERTQGGELQFQTEVE 337
+V+ + + LG+G FG VY+G D + VAVK + E + ++F E
Sbjct: 12 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 338 MISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGM 379
++ +++RL G L+V M +G + S LR +
Sbjct: 72 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL 113
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 37.0 bits (84), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSLV----AVKRLKEERTQGGELQFQTEVEMISMAV 343
F +L G FG VYKG + +G V A+K L+E + + E +++
Sbjct: 23 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 83 NPHVCRLLGICLTSTVQLITQLMPF 107
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 37.0 bits (84), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 3/69 (4%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGS-LVAVKRL--KEERTQGGELQFQTEVEMISMAVH 344
D+F LG+G FG VY R +VA+K L + +G E Q + E+E+ + H
Sbjct: 23 DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 345 RNLLRLRGF 353
N+LRL +
Sbjct: 83 PNILRLYNY 91
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 37.0 bits (84), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 19/81 (23%), Positives = 41/81 (50%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FGKVYK + + +A ++ E +++ + E+E+++ H +++L G
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 356 TPTERLLVYPFMVNGSVASCL 376
+ ++ F G+V + +
Sbjct: 79 HDGKLWIMIEFCPGGAVDAIM 99
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 37.0 bits (84), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 126
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 37.0 bits (84), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 36 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 96 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 125
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 22/61 (36%), Positives = 35/61 (57%), Gaps = 2/61 (3%)
Query: 280 LRELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVE 337
++E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 338 M 338
M
Sbjct: 61 M 61
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 22/61 (36%), Positives = 35/61 (57%), Gaps = 2/61 (3%)
Query: 280 LRELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVE 337
++E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 338 M 338
M
Sbjct: 61 M 61
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 22/61 (36%), Positives = 35/61 (57%), Gaps = 2/61 (3%)
Query: 280 LRELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVE 337
++E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 338 M 338
M
Sbjct: 61 M 61
>pdb|3G3A|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor In
Complex With A Protein Antigen
pdb|3G3A|C Chain C, Structure Of A Lamprey Variable Lymphocyte Receptor In
Complex With A Protein Antigen
pdb|3G3A|E Chain E, Structure Of A Lamprey Variable Lymphocyte Receptor In
Complex With A Protein Antigen
pdb|3G3A|G Chain G, Structure Of A Lamprey Variable Lymphocyte Receptor In
Complex With A Protein Antigen
Length = 178
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 33/84 (39%), Positives = 40/84 (47%), Gaps = 2/84 (2%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
T Q L LY N I+ P LT L LDL N L KL++L L LN+N
Sbjct: 38 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 97
Query: 153 LMGEIPR-SLTNVNSLQVLDLSNN 175
L IPR + N+ SL + L NN
Sbjct: 98 LK-SIPRGAFDNLKSLTHIWLLNN 120
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 124
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 124
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 124
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 22/64 (34%), Positives = 30/64 (46%), Gaps = 5/64 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FGKV R G VAVK LK E + E+E++ H N+++
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 351 RGFC 354
+G C
Sbjct: 77 KGIC 80
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 289 NFSNRNILGRGGFGKVYKG-RLTDGSL----VAVKRLKEERTQGGELQFQTEVEMISMAV 343
F +LG G FG VYKG + +G VA+ L+E + + E +++
Sbjct: 50 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 344 HRNLLRLRGFCMTPTERLL--VYPF 366
+ ++ RL G C+T T +L+ + PF
Sbjct: 110 NPHVCRLLGICLTSTVQLITQLMPF 134
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 32/127 (25%), Positives = 52/127 (40%), Gaps = 10/127 (7%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRL--KEERTQGGELQFQTEVEMIS 340
+ D+F LG+G FG VY R + A+K L + +G E Q + E+E+ S
Sbjct: 11 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
H N+LR+ + L+ F G + L+ F F++
Sbjct: 71 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEE 123
Query: 401 LIQSLHF 407
L +LH+
Sbjct: 124 LADALHY 130
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 36.6 bits (83), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 22/64 (34%), Positives = 30/64 (46%), Gaps = 5/64 (7%)
Query: 296 LGRGGFGKVYKGRLTD-----GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FGKV R G VAVK LK E + E+E++ H N+++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 351 RGFC 354
+G C
Sbjct: 89 KGIC 92
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 36.6 bits (83), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 19/81 (23%), Positives = 41/81 (50%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FGKVYK + + +A ++ E +++ + E+E+++ H +++L G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 356 TPTERLLVYPFMVNGSVASCL 376
+ ++ F G+V + +
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIM 107
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 36.6 bits (83), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 32/127 (25%), Positives = 52/127 (40%), Gaps = 10/127 (7%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRL--KEERTQGGELQFQTEVEMIS 340
+ D+F LG+G FG VY R + A+K L + +G E Q + E+E+ S
Sbjct: 10 KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
H N+LR+ + L+ F G + L+ F F++
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEE 122
Query: 401 LIQSLHF 407
L +LH+
Sbjct: 123 LADALHY 129
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 36.6 bits (83), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 126
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 36.6 bits (83), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 22/61 (36%), Positives = 35/61 (57%), Gaps = 2/61 (3%)
Query: 280 LRELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVE 337
++E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V
Sbjct: 23 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 338 M 338
M
Sbjct: 83 M 83
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 36.6 bits (83), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 32/127 (25%), Positives = 52/127 (40%), Gaps = 10/127 (7%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLV-AVKRL--KEERTQGGELQFQTEVEMIS 340
+ D+F LG+G FG VY R + A+K L + +G E Q + E+E+ S
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
H N+LR+ + L+ F G + L+ F F++
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEE 122
Query: 401 LIQSLHF 407
L +LH+
Sbjct: 123 LADALHY 129
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 36.6 bits (83), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 349 RLRGFCMTPTERLLVY-PFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLR 115
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 36.6 bits (83), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 349 RLRGFCMTPTERLLVY-PFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLR 115
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 36.6 bits (83), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 37/127 (29%), Positives = 58/127 (45%), Gaps = 18/127 (14%)
Query: 288 DNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVH 344
+NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFVQS 400
N+++L T + LV+ + AS L G+ P SYLF
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGI----PLPLIKSYLF------Q 110
Query: 401 LIQSLHF 407
L+Q L F
Sbjct: 111 LLQGLAF 117
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 36.6 bits (83), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
>pdb|3G39|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor
Length = 170
Score = 36.6 bits (83), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 33/84 (39%), Positives = 40/84 (47%), Gaps = 2/84 (2%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
T Q L LY N I+ P LT L LDL N L KL++L L LN+N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89
Query: 153 LMGEIPR-SLTNVNSLQVLDLSNN 175
L IPR + N+ SL + L NN
Sbjct: 90 LK-SIPRGAFDNLKSLTHIWLLNN 112
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 36.6 bits (83), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 36.6 bits (83), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 86 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 115
>pdb|3G3B|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor Mutant
In Complex With A Protein Antigen
pdb|3G3B|C Chain C, Structure Of A Lamprey Variable Lymphocyte Receptor Mutant
In Complex With A Protein Antigen
pdb|3G3B|E Chain E, Structure Of A Lamprey Variable Lymphocyte Receptor Mutant
In Complex With A Protein Antigen
pdb|3G3B|G Chain G, Structure Of A Lamprey Variable Lymphocyte Receptor Mutant
In Complex With A Protein Antigen
Length = 170
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 33/84 (39%), Positives = 40/84 (47%), Gaps = 2/84 (2%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
T Q L LY N I+ P LT L LDL N L KL++L L LN+N
Sbjct: 30 TTTQVLYLYDNRITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89
Query: 153 LMGEIPR-SLTNVNSLQVLDLSNN 175
L IPR + N+ SL + L NN
Sbjct: 90 LK-SIPRGAFDNLRSLTHIWLLNN 112
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 27/107 (25%), Positives = 48/107 (44%), Gaps = 8/107 (7%)
Query: 272 LGQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERT 325
+ Q K+ L+E+ ++ F LG FGKVYKG L VA+K LK++
Sbjct: 12 INQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 326 QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372
+F+ E + + H N++ L G +++ + +G +
Sbjct: 70 GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 116
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 349 RLRGFCMTPTERLLVY-PFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLR 115
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 36.2 bits (82), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 29 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 161
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 29 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 30 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 37/129 (28%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGR--LTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
+ +NF +G G +G VYK R LT G +VA+K+++ + T+G E+ ++
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNG----SVASCLRGMFIVSGFPSFFSYLFFIAFV 398
H N+++L T + LV+ + AS L G+ P SYLF
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGI----PLPLIKSYLF----- 113
Query: 399 QSLIQSLHF 407
L+Q L F
Sbjct: 114 -QLLQGLAF 121
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 44 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 29 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 36.2 bits (82), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 58 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 36.2 bits (82), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 16 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 36.2 bits (82), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 16 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 36.2 bits (82), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 49 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 108
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 36.2 bits (82), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 36.2 bits (82), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 17 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 36.2 bits (82), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 17 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 36.2 bits (82), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+E + + +LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 17 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 36.2 bits (82), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 28 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 88 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 117
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 35.8 bits (81), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 124
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 35.8 bits (81), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 35.8 bits (81), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLL 348
LGRG FG+V + + VAVK LKE T +E++ +I + H N++
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 349 RLRGFCMTPTERLLV-YPFMVNGSVASCLR 377
L G C P L+V F G++++ LR
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLR 126
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 35.8 bits (81), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 15 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte
Receptors Of Jawless Vertebrates By Module Engineering
Length = 279
Score = 35.8 bits (81), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 25/61 (40%), Positives = 30/61 (49%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
TNL YL LY N + LTNL LDL N L KL++L+ L LN+N
Sbjct: 133 TNLTYLYLYHNQLQSLPKGVFDKLTNLTRLDLDNNQLQSLPEGVFDKLTQLKQLSLNDNQ 192
Query: 153 L 153
L
Sbjct: 193 L 193
Score = 31.6 bits (70), Expect = 0.87, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 45/102 (44%), Gaps = 2/102 (1%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
TNL+ L L N + LTNL L LY N L KL+ L L L+NN
Sbjct: 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLYLYHNQLQSLPKGVFDKLTNLTRLDLDNNQ 168
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPIS 194
L + L+ L L++N+L +P +G F T ++
Sbjct: 169 LQSLPEGVFDKLTQLKQLSLNDNQLKS-VP-DGVFDRLTSLT 208
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 36/85 (42%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
TNL YL L N + LTNL L L N L KL+ L +L L +N
Sbjct: 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLYLYHNQ 144
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNKL 177
L + +L LDL NN+L
Sbjct: 145 LQSLPKGVFDKLTNLTRLDLDNNQL 169
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 9 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 66
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 67 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 101
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 35.8 bits (81), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 64
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 65 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 99
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 35.8 bits (81), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 64
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 65 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 99
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 35.8 bits (81), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 15 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 35.8 bits (81), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 8 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 65
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 66 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 100
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 35.8 bits (81), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 35.8 bits (81), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 64
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 65 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 99
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 35.8 bits (81), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 13 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 70
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 71 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 105
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 35.8 bits (81), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 12 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 69
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 70 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 104
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 35.8 bits (81), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 35.8 bits (81), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 16 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 73
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 74 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 108
>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor
Length = 285
Score = 35.8 bits (81), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 32/58 (55%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+L L L+ N ++ P +L L++L L+ NNL+ L L L++LRLN+N
Sbjct: 177 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 234
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 35.8 bits (81), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEER-TQGGELQFQTEVEM 338
+LG GGFG VY G R++D VA+K ++++R + GEL T V M
Sbjct: 14 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 59
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 35.8 bits (81), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 18/84 (21%), Positives = 43/84 (51%), Gaps = 1/84 (1%)
Query: 294 NILGR-GGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 352
I+G G FGKVYK + + S++A ++ + +++ + E+++++ H N+++L
Sbjct: 15 EIIGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 74
Query: 353 FCMTPTERLLVYPFMVNGSVASCL 376
++ F G+V + +
Sbjct: 75 AFYYENNLWILIEFCAGGAVDAVM 98
>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte
Receptors Of Jawless Vertebrates By Module Engineering
pdb|3RFS|B Chain B, Design Of A Binding Scaffold Based On Variable Lymphocyte
Receptors Of Jawless Vertebrates By Module Engineering
Length = 272
Score = 35.8 bits (81), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 36/83 (43%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
TNL YL L N + LTNL LDL N L KL++L+ LRL N
Sbjct: 133 TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192
Query: 153 LMGEIPRSLTNVNSLQVLDLSNN 175
L + SLQ + L +N
Sbjct: 193 LKSVPDGVFDRLTSLQYIWLHDN 215
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 30/86 (34%), Positives = 40/86 (46%), Gaps = 2/86 (2%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
TNL YL L N + LTNL L L N L KL+ L +L L +N
Sbjct: 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQ 144
Query: 153 LMGEIPRSL-TNVNSLQVLDLSNNKL 177
L +P+ + + +L LDLS N+L
Sbjct: 145 LQS-LPKGVFDKLTNLTELDLSYNQL 169
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 35.8 bits (81), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 2 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 59
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 60 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 94
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 35.4 bits (80), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 3 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 60
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 61 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 95
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 35.4 bits (80), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMIS 340
+A ++ ILG G FG+VY+G T+ VAVK K++ T + +F +E ++
Sbjct: 5 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 341 MAVHRNLLRLRGFC-MTPTERLL-VYPF 366
H ++++L G PT ++ +YP+
Sbjct: 65 NLDHPHIVKLIGIIEEEPTWIIMELYPY 92
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 35.4 bits (80), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 13 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 70
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 71 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 105
>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding
Domain Reveals A Convergent Recognition Scaffold
Mediating Inhibition Of Myelination
Length = 285
Score = 35.4 bits (80), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 32/58 (55%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+L L L+ N ++ P +L L++L L+ NNL+ L L L++LRLN+N
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 35.4 bits (80), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 17 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 74
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 75 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 109
>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin,
The Archetypal Small Leucine-Rich Repeat Proteoglycan
Length = 330
Score = 35.4 bits (80), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154
L L L N I+ L L NL L L N+++ +L LR L LNNN L+
Sbjct: 194 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253
Query: 155 GEIPRSLTNVNSLQVLDLSNNKLTG 179
++P L + +QV+ L NN ++
Sbjct: 254 -KVPGGLADHKYIQVVYLHNNNISA 277
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 35.4 bits (80), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
E +V + LG G FG+V+ G + VAVK LK+ F E ++
Sbjct: 15 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 72
Query: 342 AVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H+ L+RL +T ++ +M NGS+ L+
Sbjct: 73 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK 107
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 35.4 bits (80), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMIS 340
+A ++ ILG G FG+VY+G T+ VAVK K++ T + +F +E ++
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 341 MAVHRNLLRLRGFC-MTPTERLL-VYPF 366
H ++++L G PT ++ +YP+
Sbjct: 69 NLDHPHIVKLIGIIEEEPTWIIMELYPY 96
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 35.4 bits (80), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 285 VATDNFSNRNILGRGGFGKVYKGRLTDGSL----VAVKRLKEERTQGGELQFQTEVEMIS 340
+A ++ ILG G FG+VY+G T+ VAVK K++ T + +F +E ++
Sbjct: 21 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 341 MAVHRNLLRLRGFC-MTPTERLL-VYPF 366
H ++++L G PT ++ +YP+
Sbjct: 81 NLDHPHIVKLIGIIEEEPTWIIMELYPY 108
>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1
pdb|1XEC|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 2
pdb|1XEC|B Chain B, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 2
Length = 329
Score = 35.4 bits (80), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 41/85 (48%), Gaps = 1/85 (1%)
Query: 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154
L L L N I+ L L NL L L N+++ +L LR L LNNN L+
Sbjct: 194 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253
Query: 155 GEIPRSLTNVNSLQVLDLSNNKLTG 179
++P L + +QV+ L NN ++
Sbjct: 254 -KVPGGLADHKYIQVVYLHNNNISA 277
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 35.4 bits (80), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 26/72 (36%), Positives = 40/72 (55%), Gaps = 9/72 (12%)
Query: 296 LGRGGFGKV--YKGRLTD---GSLVAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLL 348
LG G FGKV Y T+ G +VAVK LKE G +L+ +Q E+E++ H +++
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE--GCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 349 RLRGFCMTPTER 360
+ +G C E+
Sbjct: 74 KYKGCCEDQGEK 85
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 35.4 bits (80), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 26/72 (36%), Positives = 40/72 (55%), Gaps = 9/72 (12%)
Query: 296 LGRGGFGKV--YKGRLTD---GSLVAVKRLKEERTQGGELQ--FQTEVEMISMAVHRNLL 348
LG G FGKV Y T+ G +VAVK LKE G +L+ +Q E+E++ H +++
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE--GCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 349 RLRGFCMTPTER 360
+ +G C E+
Sbjct: 75 KYKGCCEDQGEK 86
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 35.4 bits (80), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKR-LKEERTQGGELQFQTEVEMISMAV 343
+ + + N ++G G +G V K R D G +VA+K+ L+ + + + E++++
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 344 HRNLLRLRGFCMTPTERLLVYPFM 367
H NL+ L C LV+ F+
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFV 106
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 35.0 bits (79), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 38/82 (46%), Gaps = 2/82 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG V G+ VAVK +KE E FQ M+ ++ H L++ G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEF-FQEAQTMMKLS-HPKLVKFYGVCS 73
Query: 356 TPTERLLVYPFMVNGSVASCLR 377
+V ++ NG + + LR
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLR 95
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 35.0 bits (79), Expect = 0.080, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRG 352
LG G FG+V+ G + + VAVK LK G + Q E ++ H L+RL
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLKP-----GTMSVQAFLEEANLMKTLQHDKLVRLYA 74
Query: 353 FCMTPTERLLVYPFMVNGSVASCLR 377
++ FM GS+ L+
Sbjct: 75 VVTKEEPIYIITEFMAKGSLLDFLK 99
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 35.0 bits (79), Expect = 0.083, Method: Compositional matrix adjust.
Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 5/74 (6%)
Query: 294 NILGRGGFGKVYKG-RLTDGS----LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
+LG G FG VYKG + DG VA+K L+E + + E +++ +
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 349 RLRGFCMTPTERLL 362
RL G C+T T +L+
Sbjct: 83 RLLGICLTSTVQLV 96
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 35.0 bits (79), Expect = 0.087, Method: Compositional matrix adjust.
Identities = 20/63 (31%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G+G FG+V+K R G VA+K+ L E +G + E++++ + H N++ L
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 354 CMT 356
C T
Sbjct: 86 CRT 88
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 34.7 bits (78), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 20/63 (31%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G+G FG+V+K R G VA+K+ L E +G + E++++ + H N++ L
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 354 CMT 356
C T
Sbjct: 86 CRT 88
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 34.7 bits (78), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK + T+ +E+EM+ M H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ L+
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQA 127
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 34.7 bits (78), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK + T+ +E+EM+ M H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ L+
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQA 168
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 34.7 bits (78), Expect = 0.093, Method: Compositional matrix adjust.
Identities = 20/63 (31%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G+G FG+V+K R G VA+K+ L E +G + E++++ + H N++ L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 354 CMT 356
C T
Sbjct: 85 CRT 87
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 34.7 bits (78), Expect = 0.093, Method: Compositional matrix adjust.
Identities = 20/63 (31%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 296 LGRGGFGKVYKGR-LTDGSLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
+G+G FG+V+K R G VA+K+ L E +G + E++++ + H N++ L
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 354 CMT 356
C T
Sbjct: 86 CRT 88
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 34.7 bits (78), Expect = 0.095, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK + T+ +E+EM+ M H+N
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ L+
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREYLQA 116
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 34.7 bits (78), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK + T+ +E+EM+ M H+N
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ L+
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREYLQA 120
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK + T+ +E+EM+ M H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ L+
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQA 127
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK + T+ +E+EM+ M H+N
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ L+
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREYLQA 119
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK + T+ +E+EM+ M H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ L+
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQA 127
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK + T+ +E+EM+ M H+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ L+
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQA 112
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 27/74 (36%), Positives = 35/74 (47%), Gaps = 6/74 (8%)
Query: 296 LGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLR 349
LG G FG V +G S VAVK LK + E F EV + HRNL+R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 350 LRGFCMTPTERLLV 363
L G +TP +++
Sbjct: 80 LYGVVLTPPMKMVT 93
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 34.7 bits (78), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 3/63 (4%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 354
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 355 MTP 357
P
Sbjct: 74 TAP 76
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 34.7 bits (78), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 9/92 (9%)
Query: 296 LGRGGFGKVY--------KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISM-AVHRN 346
LG G FG+V K + + VAVK LK + T+ +E+EM+ M H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLRG 378
++ L G C ++ + G++ L+
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQA 127
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 34.7 bits (78), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 27/74 (36%), Positives = 35/74 (47%), Gaps = 6/74 (8%)
Query: 296 LGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLR 349
LG G FG V +G S VAVK LK + E F EV + HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 350 LRGFCMTPTERLLV 363
L G +TP +++
Sbjct: 76 LYGVVLTPPMKMVT 89
>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex
pdb|4B8C|J Chain J, Nuclease Module Of The Yeast Ccr4-Not Complex
pdb|4B8C|K Chain K, Nuclease Module Of The Yeast Ccr4-Not Complex
pdb|4B8C|L Chain L, Nuclease Module Of The Yeast Ccr4-Not Complex
Length = 727
Score = 34.7 bits (78), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/70 (32%), Positives = 38/70 (54%), Gaps = 2/70 (2%)
Query: 108 KVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSL 167
++P E+ NL+NL LDL N L +P LG +L++ +N ++ +P N+ +L
Sbjct: 261 ELPAEIKNLSNLRVLDLSHNRLTS-LPAELGSCFQLKYFYFFDN-MVTTLPWEFGNLCNL 318
Query: 168 QVLDLSNNKL 177
Q L + N L
Sbjct: 319 QFLGVEGNPL 328
Score = 33.9 bits (76), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 21/47 (44%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 133 IPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKLTG 179
I + K L L LN NSL E+P + N+++L+VLDLS+N+LT
Sbjct: 239 ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTS 284
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 3/63 (4%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 354
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 21 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 355 MTP 357
P
Sbjct: 79 TKP 81
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 27/73 (36%), Positives = 35/73 (47%), Gaps = 6/73 (8%)
Query: 296 LGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLR 349
LG G FG V +G S VAVK LK + E F EV + HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 350 LRGFCMTPTERLL 362
L G +TP +++
Sbjct: 76 LYGVVLTPPMKMV 88
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 27/73 (36%), Positives = 35/73 (47%), Gaps = 6/73 (8%)
Query: 296 LGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLR 349
LG G FG V +G S VAVK LK + E F EV + HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 350 LRGFCMTPTERLL 362
L G +TP +++
Sbjct: 76 LYGVVLTPPMKMV 88
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 34.3 bits (77), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 3/63 (4%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 354
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 18 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 355 MTP 357
P
Sbjct: 76 TKP 78
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 3/63 (4%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 354
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 355 MTP 357
P
Sbjct: 74 TKP 76
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 3/63 (4%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 354
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 21 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 355 MTP 357
P
Sbjct: 79 TKP 81
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 3/63 (4%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 354
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 355 MTP 357
P
Sbjct: 74 TKP 76
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 27/74 (36%), Positives = 35/74 (47%), Gaps = 6/74 (8%)
Query: 296 LGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLR 349
LG G FG V +G S VAVK LK + E F EV + HRNL+R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 350 LRGFCMTPTERLLV 363
L G +TP +++
Sbjct: 80 LYGVVLTPPMKMVT 93
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 34.3 bits (77), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 27/74 (36%), Positives = 35/74 (47%), Gaps = 6/74 (8%)
Query: 296 LGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLR 349
LG G FG V +G S VAVK LK + E F EV + HRNL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 350 LRGFCMTPTERLLV 363
L G +TP +++
Sbjct: 86 LYGVVLTPPMKMVT 99
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 34.3 bits (77), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 27/74 (36%), Positives = 35/74 (47%), Gaps = 6/74 (8%)
Query: 296 LGRGGFGKVYKGRLTDGS----LVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLR 349
LG G FG V +G S VAVK LK + E F EV + HRNL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 350 LRGFCMTPTERLLV 363
L G +TP +++
Sbjct: 86 LYGVVLTPPMKMVT 99
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 34.3 bits (77), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 28/109 (25%), Positives = 52/109 (47%), Gaps = 11/109 (10%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGRLT--DGSL--VAVKRLKEERTQGGEL-QFQ 333
L ++ + F+ +LG+G FG V + +L DGS VAVK LK + ++ +F
Sbjct: 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 334 TEVEMISMAVHRNLLRLRGFCMTPTER------LLVYPFMVNGSVASCL 376
E + H ++ +L G + + +++ PFM +G + + L
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL 122
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 34.3 bits (77), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 21/68 (30%), Positives = 34/68 (50%), Gaps = 2/68 (2%)
Query: 286 ATDNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLK-EERTQGGELQFQTEVEMISMAV 343
+ D + LG G +G+VYK T VA+KR++ E +G EV ++
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 344 HRNLLRLR 351
HRN++ L+
Sbjct: 92 HRNIIELK 99
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 33.9 bits (76), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 38/83 (45%), Gaps = 3/83 (3%)
Query: 276 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQT 334
+R S + ++ + +G G FG VYKG+ VAVK L +LQ F+
Sbjct: 16 RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKN 73
Query: 335 EVEMISMAVHRNLLRLRGFCMTP 357
EV ++ H N+L G+ P
Sbjct: 74 EVGVLRKTRHVNILLFMGYSTKP 96
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 33.9 bits (76), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 40/85 (47%), Gaps = 1/85 (1%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
Q + + +G G +G VYK + + G +VA+KR++ + +G E+ ++
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFM 367
H N++ L + LV+ FM
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFM 101
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 33.9 bits (76), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 40/85 (47%), Gaps = 1/85 (1%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMA 342
Q + + +G G +G VYK + + G +VA+KR++ + +G E+ ++
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFM 367
H N++ L + LV+ FM
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFM 101
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 20/75 (26%), Positives = 38/75 (50%), Gaps = 2/75 (2%)
Query: 279 SLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVE 337
L E D +R +LG+G +G VY GR L++ +A+K + E ++ + E+
Sbjct: 13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIA 71
Query: 338 MISMAVHRNLLRLRG 352
+ H+N+++ G
Sbjct: 72 LHKHLKHKNIVQYLG 86
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 38/83 (45%), Gaps = 3/83 (3%)
Query: 276 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQT 334
+R S + ++ + +G G FG VYKG+ VAVK L +LQ F+
Sbjct: 24 RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKN 81
Query: 335 EVEMISMAVHRNLLRLRGFCMTP 357
EV ++ H N+L G+ P
Sbjct: 82 EVGVLRKTRHVNILLFMGYSTKP 104
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 26/100 (26%), Positives = 50/100 (50%), Gaps = 8/100 (8%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMIS 340
E D +R +LG+G +G VY GR L++ +A+K + E ++ + E+ +
Sbjct: 2 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHK 60
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVN---GSVASCLR 377
H+N+++ G + +E + FM GS+++ LR
Sbjct: 61 HLKHKNIVQYLG---SFSENGFIKIFMEQVPGGSLSALLR 97
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 38/83 (45%), Gaps = 3/83 (3%)
Query: 276 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQT 334
+R S + ++ + +G G FG VYKG+ VAVK L +LQ F+
Sbjct: 23 RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKN 80
Query: 335 EVEMISMAVHRNLLRLRGFCMTP 357
EV ++ H N+L G+ P
Sbjct: 81 EVGVLRKTRHVNILLFMGYSTKP 103
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 13/106 (12%)
Query: 273 GQLKRFSLRELQVATDNFSNRNILGRGGFGKVYKGRL------TDGSLVAVKRLKEERTQ 326
G+LK SL ++ + LG FGKVYKG L VA+K LK++
Sbjct: 1 GKLKEISLSAVRFMEE-------LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG 53
Query: 327 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372
+F+ E + + H N++ L G +++ + +G +
Sbjct: 54 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 99
>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte
Receptors A29
Length = 270
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 36/84 (42%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
NL L L N + P +LT L L L N L KL+ L+ LRL NN L
Sbjct: 110 NLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169
Query: 154 MGEIPRSLTNVNSLQVLDLSNNKL 177
+ + L+ L L NN+L
Sbjct: 170 KRVPEGAFDKLTELKTLKLDNNQL 193
>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g
And T399i In Complex With Md-2 And Lps
pdb|4G8A|B Chain B, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g
And T399i In Complex With Md-2 And Lps
Length = 635
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 1/86 (1%)
Query: 93 TNLQYLELYSNNISGK-VPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
++L+ L++ N+ +P+ L NL LDL L PT LS L+ L +++N
Sbjct: 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 528
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKL 177
+ +NSLQVLD S N +
Sbjct: 529 NFFSLDTFPYKCLNSLQVLDYSLNHI 554
Score = 28.5 bits (62), Expect = 7.4, Method: Compositional matrix adjust.
Identities = 23/67 (34%), Positives = 40/67 (59%), Gaps = 6/67 (8%)
Query: 113 LGNLTNLVSLDLYLNNL-NGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVL 170
L +L LV+++ L +L N PI G L L+ L + +N + ++P +N+ +L+ L
Sbjct: 123 LSSLQKLVAVETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 178
Query: 171 DLSNNKL 177
DLS+NK+
Sbjct: 179 DLSSNKI 185
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 38/83 (45%), Gaps = 3/83 (3%)
Query: 276 KRFSLRELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQT 334
+R S + ++ + +G G FG VYKG+ VAVK L +LQ F+
Sbjct: 24 RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKN 81
Query: 335 EVEMISMAVHRNLLRLRGFCMTP 357
EV ++ H N+L G+ P
Sbjct: 82 EVGVLRKTRHVNILLFMGYSTKP 104
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 296 LGRGGFGKV--YKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FGKV Y T+ G +VAVK LK + ++ E++++ H ++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 351 RGFCMTPTERLL 362
+G C E+ L
Sbjct: 82 KGCCEDQGEKSL 93
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 33.9 bits (76), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 22/72 (30%), Positives = 37/72 (51%), Gaps = 5/72 (6%)
Query: 296 LGRGGFGKV--YKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FGKV Y T+ G +VAVK LK + ++ E++++ H ++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 351 RGFCMTPTERLL 362
+G C E+ L
Sbjct: 82 KGCCEDQGEKSL 93
>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And
Hagfish Vlrb.61
pdb|2Z66|B Chain B, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And
Hagfish Vlrb.61
pdb|2Z66|C Chain C, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And
Hagfish Vlrb.61
pdb|2Z66|D Chain D, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And
Hagfish Vlrb.61
Length = 306
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 1/86 (1%)
Query: 93 TNLQYLELYSNNISGK-VPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
++L+ L++ N+ +P+ L NL LDL L PT LS L+ L +++N
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKL 177
+ +NSLQVLD S N +
Sbjct: 210 NFFSLDTFPYKCLNSLQVLDYSLNHI 235
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 24/85 (28%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQT---EVEMISMAVHRNLLRLRG 352
LG G FG+V+ G + + VAVK LK G + Q E ++ H L+RL
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLKP-----GTMSVQAFLEEANLMKTLQHDKLVRLYA 75
Query: 353 FCMTPTERLLVYPFMVNGSVASCLR 377
++ +M GS+ L+
Sbjct: 76 VVTREEPIYIITEYMAKGSLLDFLK 100
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 33.5 bits (75), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYK-------GRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG G FGKV K GR + VAVK LKE + +E ++ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+L G C LL+ + GS+ LR
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 3/63 (4%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 354
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 20 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 355 MTP 357
P
Sbjct: 78 TKP 80
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 21/84 (25%), Positives = 36/84 (42%), Gaps = 1/84 (1%)
Query: 290 FSNRNILGRGGFGKVY-KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
F + LG G F +V G L AVK + ++ +G E + E+ ++ H N++
Sbjct: 24 FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 349 RLRGFCMTPTERLLVYPFMVNGSV 372
L +P LV + G +
Sbjct: 84 ALEDIYESPNHLYLVMQLVSGGEL 107
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 33.5 bits (75), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 3/63 (4%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 354
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 355 MTP 357
P
Sbjct: 90 TAP 92
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 33.5 bits (75), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYK-------GRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG G FGKV K GR + VAVK LKE + +E ++ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+L G C LL+ + GS+ LR
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 33.5 bits (75), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 8/89 (8%)
Query: 296 LGRGGFGKVYK-------GRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 348
LG G FGKV K GR + VAVK LKE + +E ++ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+L G C LL+ + GS+ LR
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLR 118
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 33.5 bits (75), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 20/82 (24%), Positives = 40/82 (48%)
Query: 291 SNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
S ILG G FG+V+K T L ++ + R + + + E+ +++ H NL++L
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 351 RGFCMTPTERLLVYPFMVNGSV 372
+ + +LV ++ G +
Sbjct: 152 YDAFESKNDIVLVMEYVDGGEL 173
>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps
Ra Complex
pdb|3FXI|B Chain B, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps
Ra Complex
Length = 605
Score = 33.5 bits (75), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 1/86 (1%)
Query: 93 TNLQYLELYSNNISGK-VPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
++L+ L++ N+ +P+ L NL LDL L PT LS L+ L +++N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 152 SLMGEIPRSLTNVNSLQVLDLSNNKL 177
+ +NSLQVLD S N +
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHI 530
Score = 28.1 bits (61), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 23/67 (34%), Positives = 40/67 (59%), Gaps = 6/67 (8%)
Query: 113 LGNLTNLVSLDLYLNNL-NGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVL 170
L +L LV+++ L +L N PI G L L+ L + +N + ++P +N+ +L+ L
Sbjct: 99 LSSLQKLVAVETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 171 DLSNNKL 177
DLS+NK+
Sbjct: 155 DLSSNKI 161
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 33.1 bits (74), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 3/63 (4%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGFC 354
+G G FG VYKG+ VAVK L +LQ F+ EV ++ H N+L G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 355 MTP 357
P
Sbjct: 90 TKP 92
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 33.1 bits (74), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 2/82 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRGFC 354
+G G FG V++ GS VAVK L E+ + +F EV ++ H N++ G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 355 MTPTERLLVYPFMVNGSVASCL 376
P +V ++ GS+ L
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLL 125
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 33.1 bits (74), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 3/81 (3%)
Query: 272 LGQLKRFSLRELQVATDNFSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGE 329
LG ++ ++ + D + R++LG G F +V + + T LVA+K + +E +G E
Sbjct: 2 LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCIAKEALEGKE 60
Query: 330 LQFQTEVEMISMAVHRNLLRL 350
+ E+ ++ H N++ L
Sbjct: 61 GSMENEIAVLHKIKHPNIVAL 81
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 33.1 bits (74), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 2/82 (2%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRGFC 354
+G G FG V++ GS VAVK L E+ + +F EV ++ H N++ G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 355 MTPTERLLVYPFMVNGSVASCL 376
P +V ++ GS+ L
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLL 125
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 33.1 bits (74), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 20/64 (31%), Positives = 34/64 (53%), Gaps = 5/64 (7%)
Query: 296 LGRGGFGKV--YKGRLTD---GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 350
LG G FGKV Y T+ G +VAVK LK + ++ E++++ H ++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 351 RGFC 354
+G C
Sbjct: 99 KGCC 102
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 33.1 bits (74), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 3/81 (3%)
Query: 272 LGQLKRFSLRELQVATDNFSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGE 329
LG ++ ++ + D + R++LG G F +V + + T LVA+K + +E +G E
Sbjct: 2 LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCIAKEALEGKE 60
Query: 330 LQFQTEVEMISMAVHRNLLRL 350
+ E+ ++ H N++ L
Sbjct: 61 GSMENEIAVLHKIKHPNIVAL 81
>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist
Antibody
pdb|3KJ4|D Chain D, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist
Antibody
Length = 286
Score = 32.7 bits (73), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 33/58 (56%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNN 151
+L L L+ N+++ P +L L++L L+ NNL+ L L L++LRLN+N
Sbjct: 177 SLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNLSMLPAEVLVPLRSLQYLRLNDN 234
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 40/92 (43%), Gaps = 2/92 (2%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLN-NLNGPIPTTLGKLSKLRFLRLNNNS 152
NL L L+SN ++G LT L LDL N L PTT L L L L+
Sbjct: 56 NLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLRVVDPTTFRGLGHLHTLHLDRCG 115
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNKLTGDIPTN 184
L P + +LQ L L +N L +P N
Sbjct: 116 LQELGPGLFRGLAALQYLYLQDNNLQA-LPDN 146
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 32.7 bits (73), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 3/81 (3%)
Query: 272 LGQLKRFSLRELQVATDNFSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGE 329
LG ++ ++ + D + R++LG G F +V + + T LVA+K + +E +G E
Sbjct: 2 LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCIAKEALEGKE 60
Query: 330 LQFQTEVEMISMAVHRNLLRL 350
+ E+ ++ H N++ L
Sbjct: 61 GSMENEIAVLHKIKHPNIVAL 81
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 32.7 bits (73), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 22/34 (64%), Gaps = 1/34 (2%)
Query: 295 ILGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQG 327
+LG+GGFG V+ G RLTD VA+K + R G
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG 71
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 32.7 bits (73), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 39/80 (48%), Gaps = 4/80 (5%)
Query: 275 LKRFSLRELQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQ 333
L L L+ F ++G G +G+VYKGR + G L A+K + + T E + +
Sbjct: 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIK 68
Query: 334 TEVEMISM-AVHRNLLRLRG 352
E+ M+ + HRN+ G
Sbjct: 69 QEINMLKKYSHHRNIATYYG 88
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 32.7 bits (73), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 15/120 (12%)
Query: 296 LGRGGFGKVYKGRLTD----GSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG+G F K++KG + G L V +K L + E F+ M+S H++L
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLRGMFIVSGFPSFFSYLFFIAFVQSLIQSLHF 407
+ G C+ E +LV F+ GS+ + L+ + + L+ + + L ++HF
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKN------KNCINILWKLEVAKQLAAAMHF 128
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 32.3 bits (72), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 19/74 (25%), Positives = 36/74 (48%), Gaps = 2/74 (2%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+F +GRGGFG V++ + D A+KR++ + + EV+ ++ H +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 348 LR-LRGFCMTPTER 360
+R + TP E+
Sbjct: 67 VRYFNAWLETPPEK 80
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 32.3 bits (72), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 32/111 (28%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 273 GQLKRFSLRELQVATDN---FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGG 328
G LK + EL D FS+ +G G FG VY R + + +VA+K++ Q
Sbjct: 36 GSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN 95
Query: 329 ELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCL 376
E ++Q EV + H N ++ RG + LV + + GS + L
Sbjct: 96 E-KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL 144
>pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor
Vlra.R5.1
pdb|3M19|B Chain B, Crystal Structure Of Variable Lymphocyte Receptor
Vlra.R5.1
Length = 251
Score = 32.3 bits (72), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 29/79 (36%), Positives = 39/79 (49%), Gaps = 5/79 (6%)
Query: 102 SNNISGKVPEELGNLTNLVSLD-LYL--NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP 158
+NN +P LG +L LD LYL N L +L+KL+ LRLN N L
Sbjct: 91 ANNQLASLP--LGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA 148
Query: 159 RSLTNVNSLQVLDLSNNKL 177
+ + +LQ L LS N+L
Sbjct: 149 GAFDKLTNLQTLSLSTNQL 167
>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr)
Rbc36 In Complex With H-Trisaccharide
Length = 229
Score = 32.3 bits (72), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 32/103 (31%), Positives = 47/103 (45%), Gaps = 3/103 (2%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
NL+ L L SN + +LT L LDL N L +L L+ L + N L
Sbjct: 65 NLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL 124
Query: 154 MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNGSFSLFTPISFA 196
E+PR + + L L L N+L IP +G+F + ++ A
Sbjct: 125 T-ELPRGIERLTHLTHLALDQNQLKS-IP-HGAFDRLSSLTHA 164
>pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor
Vlra.R2.1 In Complex With Hen Egg Lysozyme
Length = 251
Score = 32.3 bits (72), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 29/79 (36%), Positives = 39/79 (49%), Gaps = 5/79 (6%)
Query: 102 SNNISGKVPEELGNLTNLVSLD-LYL--NNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIP 158
+NN +P LG +L LD LYL N L +L+KL+ LRLN N L
Sbjct: 91 ANNQLASLP--LGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA 148
Query: 159 RSLTNVNSLQVLDLSNNKL 177
+ + +LQ L LS N+L
Sbjct: 149 GAFDKLTNLQTLSLSTNQL 167
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 32.0 bits (71), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 9/90 (10%)
Query: 296 LGRGGFGKVYKGRLTD----GSL----VAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
LG+G F K++KG + G L V +K L + E F+ M+S H++L
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 348 LRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+ G C E +LV F+ GS+ + L+
Sbjct: 75 VLNYGVCFCGDENILVQEFVKFGSLDTYLK 104
>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain
pdb|3CIY|A Chain A, Mouse Toll-Like Receptor 3 Ectodomain Complexed With
Double-Stranded Rna
pdb|3CIY|B Chain B, Mouse Toll-Like Receptor 3 Ectodomain Complexed With
Double-Stranded Rna
Length = 697
Score = 32.0 bits (71), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 27/82 (32%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 93 TNLQYLELYSNNISGKVPEELGNL--TNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNN 150
T++Q L L +N + L TNL LDL NNL+ + L LR+L L
Sbjct: 222 TSIQNLSLANNQLLATSESTFSGLKWTNLTQLDLSYNNLHDVGNGSFSYLPSLRYLSLEY 281
Query: 151 NSLMGEIPRSLTNVNSLQVLDL 172
N++ PRS +++L+ L L
Sbjct: 282 NNIQRLSPRSFYGLSNLRYLSL 303
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 32.0 bits (71), Expect = 0.64, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 3/93 (3%)
Query: 288 DNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRL-KEERTQGGELQ-FQTEVEMISMAVH 344
++F N+LG+G F VY+ + G VA+K + K+ + G +Q Q EV++ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++L L + LV NG + L+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK 103
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 32.0 bits (71), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 26/91 (28%), Positives = 43/91 (47%), Gaps = 6/91 (6%)
Query: 290 FSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHR 345
FS+ +G G FG VY R + + +VA+K++ Q E ++Q EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 346 NLLRLRGFCMTPTERLLVYPFMVNGSVASCL 376
N ++ RG + LV + + GS + L
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCL-GSASDLL 105
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 32.0 bits (71), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 18/65 (27%), Positives = 33/65 (50%), Gaps = 6/65 (9%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+F ++G GGFG+V+K + DG +KR+K + + EV+ ++ H N+
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA-----EREVKALAKLDHVNI 66
Query: 348 LRLRG 352
+ G
Sbjct: 67 VHYNG 71
>pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex
Length = 562
Score = 32.0 bits (71), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 47/78 (60%), Gaps = 5/78 (6%)
Query: 118 NLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQVLDLSNNKL 177
+++ L+L N L G + L K++ L L+NN +M IP+ +T++ +LQ L++++N+L
Sbjct: 429 SILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL 485
Query: 178 TGDIPTNGSFSLFTPISF 195
+P +G F T + +
Sbjct: 486 KS-VP-DGVFDRLTSLQY 501
>pdb|2R9U|A Chain A, Crystal Structure Of Lamprey Variable Lymphocyte Receptor
2913 Ectodomain
pdb|2R9U|B Chain B, Crystal Structure Of Lamprey Variable Lymphocyte Receptor
2913 Ectodomain
pdb|2R9U|C Chain C, Crystal Structure Of Lamprey Variable Lymphocyte Receptor
2913 Ectodomain
pdb|2R9U|D Chain D, Crystal Structure Of Lamprey Variable Lymphocyte Receptor
2913 Ectodomain
Length = 174
Score = 32.0 bits (71), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 33/85 (38%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPT-TLGKLSKLRFLRLNNN 151
T+ Q L L +N I+ P +L NL L N L IPT KL++L L LN+N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDN 91
Query: 152 SLMGEIPR-SLTNVNSLQVLDLSNN 175
L IPR + N+ SL + L NN
Sbjct: 92 HLKS-IPRGAFDNLKSLTHIYLYNN 115
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 31.6 bits (70), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 25/75 (33%), Positives = 36/75 (48%), Gaps = 7/75 (9%)
Query: 296 LGRGGFGKVYKG------RLTDGSLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLL 348
LGRG FGKV + + VAVK LKE T TE+++++ + H N++
Sbjct: 35 LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 349 RLRGFCMTPTERLLV 363
L G C L+V
Sbjct: 95 NLLGACTKQGGPLMV 109
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 31.6 bits (70), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 3/82 (3%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G G+V+ G + VAVK LK+ F E ++ H+ L+RL +
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 356 TPTERLLVYPFMVNGSVASCLR 377
T ++ +M NGS+ L+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLK 99
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 31.6 bits (70), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 25/73 (34%), Positives = 36/73 (49%), Gaps = 5/73 (6%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMIS 340
E++ + S R +G G FG VYKG+ VAVK LK + Q F+ EV ++
Sbjct: 32 EIEASEVMLSTR--IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 341 MAVHRNLLRLRGF 353
H N+L G+
Sbjct: 88 KTRHVNILLFMGY 100
>pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4
pdb|2WFH|B Chain B, The Human Slit 2 Dimerization Domain D4
Length = 193
Score = 31.6 bits (70), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 25/87 (28%), Positives = 41/87 (47%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
+L ++L +N IS + N+T L++L L N L P T L LR L L+ N +
Sbjct: 55 HLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDI 114
Query: 154 MGEIPRSLTNVNSLQVLDLSNNKLTGD 180
+ ++++L L + N L D
Sbjct: 115 SVVPEGAFNDLSALSHLAIGANPLYCD 141
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 24/86 (27%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 109 VPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLMGEIPRSLTNVNSLQ 168
VP+EL N +L +DL N ++ + +++L L L+ N L PR+ + SL+
Sbjct: 46 VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLR 105
Query: 169 VLDLSNNKLTGDIPTNGSFSLFTPIS 194
+L L N ++ + G+F+ + +S
Sbjct: 106 LLSLHGNDIS--VVPEGAFNDLSALS 129
>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX
Length = 462
Score = 31.6 bits (70), Expect = 0.91, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 56/113 (49%), Gaps = 18/113 (15%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
TNL L L++N I+ P L NLTNL L+L N ++ + L L+ L+ L ++N
Sbjct: 107 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQ 162
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNK------------LTGDIPTNGSFSLFTPI 193
+ P L N+ +L+ LD+S+NK L I TN S TP+
Sbjct: 163 VTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL 213
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
T L+ L++ SN +S L LTNL SL N ++ P LG L+ L L LN N
Sbjct: 173 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQ 228
Query: 153 L--MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
L +G + SLTN L LDL+NN+++ P +G
Sbjct: 229 LKDIGTL-ASLTN---LTDLDLANNQISNLAPLSG 259
>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex
Length = 462
Score = 31.6 bits (70), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 56/113 (49%), Gaps = 18/113 (15%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
TNL L L++N I+ P L NLTNL L+L N ++ + L L+ L+ L ++N
Sbjct: 107 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFSSNQ 162
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNK------------LTGDIPTNGSFSLFTPI 193
+ P L N+ +L+ LD+S+NK L I TN S TP+
Sbjct: 163 VTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL 213
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
T L+ L++ SN +S L LTNL SL N ++ P LG L+ L L LN N
Sbjct: 173 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQ 228
Query: 153 L--MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
L +G + SLTN L LDL+NN+++ P +G
Sbjct: 229 LKDIGTL-ASLTN---LTDLDLANNQISNLAPLSG 259
>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX
Length = 462
Score = 31.2 bits (69), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 56/113 (49%), Gaps = 18/113 (15%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
TNL L L++N I+ P L NLTNL L+L N ++ + L L+ L+ L ++N
Sbjct: 107 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFSSNQ 162
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNK------------LTGDIPTNGSFSLFTPI 193
+ P L N+ +L+ LD+S+NK L I TN S TP+
Sbjct: 163 VTDLKP--LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL 213
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
T L+ L++ SN +S L LTNL SL N ++ P LG L+ L L LN N
Sbjct: 173 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQ 228
Query: 153 L--MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
L +G + SLTN L LDL+NN+++ P +G
Sbjct: 229 LKDIGTL-ASLTN---LTDLDLANNQISNLAPLSG 259
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKG 271
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKG 271
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 17/65 (26%), Positives = 33/65 (50%), Gaps = 6/65 (9%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+F ++G GGFG+V+K + DG ++R+K + + EV+ ++ H N+
Sbjct: 13 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA-----EREVKALAKLDHVNI 67
Query: 348 LRLRG 352
+ G
Sbjct: 68 VHYNG 72
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 18/73 (24%), Positives = 36/73 (49%), Gaps = 1/73 (1%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G +G VYK + G A+K+++ E+ +G E+ ++ H N+++L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 355 MTPTERLLVYPFM 367
T +LV+ +
Sbjct: 70 HTKKRLVLVFEHL 82
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 18/73 (24%), Positives = 36/73 (49%), Gaps = 1/73 (1%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G +G VYK + G A+K+++ E+ +G E+ ++ H N+++L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 355 MTPTERLLVYPFM 367
T +LV+ +
Sbjct: 70 HTKKRLVLVFEHL 82
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 18/73 (24%), Positives = 36/73 (49%), Gaps = 1/73 (1%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 354
+G G +G VYK + G A+K+++ E+ +G E+ ++ H N+++L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 355 MTPTERLLVYPFM 367
T +LV+ +
Sbjct: 70 HTKKRLVLVFEHL 82
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLL 348
LG G FGKV + D L VAVK LK + +E++++S + H N++
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
L G C L++ + G + + LR
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR 142
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 21/79 (26%), Positives = 41/79 (51%), Gaps = 3/79 (3%)
Query: 296 LGRGGFGKV-YKGRLTDGSLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRGF 353
+G GGF KV + G +VA+K + ++ T G +L + +TE+E + H+++ +L
Sbjct: 18 IGTGGFAKVKLACHILTGEMVAIK-IMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHV 76
Query: 354 CMTPTERLLVYPFMVNGSV 372
T + +V + G +
Sbjct: 77 LETANKIFMVLEYCPGGEL 95
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS- 340
+N LG G FGKV + D L VAVK LK + +E++++S
Sbjct: 31 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+ H N++ L G C L++ + G + + LR
Sbjct: 91 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 127
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS- 340
+N LG G FGKV + D L VAVK LK + +E++++S
Sbjct: 38 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
+ H N++ L G C L++ + G + + LR
Sbjct: 98 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 20/57 (35%), Positives = 31/57 (54%), Gaps = 2/57 (3%)
Query: 296 LGRGGFGKVYKGRLTDGSL-VAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRL 350
+GRG F VYKG T+ ++ VA L++ + E Q F+ E E + H N++R
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 47/111 (42%), Gaps = 7/111 (6%)
Query: 287 TDNFSNRNILGRGGFG--KVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVH 344
+D + +G G FG ++ + +LT LVAVK + ER + Q E+ H
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLT-KELVAVKYI--ERGAAIDENVQREIINHRSLRH 75
Query: 345 RNLLRLRGFCMTPTERLLVYPFMVNGSVAS--CLRGMFIVSGFPSFFSYLF 393
N++R + +TPT ++ + G + C G F FF L
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL 126
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLL 348
LG G FGKV + D L VAVK LK + +E++++S + H N++
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
L G C L++ + G + + LR
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR 142
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 25/108 (23%), Positives = 51/108 (47%), Gaps = 2/108 (1%)
Query: 272 LGQLKRFSLRELQVATDN-FSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGE 329
+ L+ F+ + +V + F+ + +G+G FG+VYKG +VA+K + E +
Sbjct: 2 MAHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEI 61
Query: 330 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
Q E+ ++S + R G + T+ ++ ++ GS L+
Sbjct: 62 EDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLK 109
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/90 (26%), Positives = 42/90 (46%), Gaps = 10/90 (11%)
Query: 287 TDNFSNRNILGRGGFGKVY----KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMA 342
+D F + LGRG VY KG +L +K+ +++ +TE+ ++
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI------VRTEIGVLLRL 105
Query: 343 VHRNLLRLRGFCMTPTERLLVYPFMVNGSV 372
H N+++L+ TPTE LV + G +
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGEL 135
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 74
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 75 VSEEPIYIVTEYMSKGSLLDFLKG 98
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 70
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 71 VSEEPIYIVTEYMSKGSLLDFLKG 94
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 330
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKG 354
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKIRHEKLVQL--YAV 81
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 82 VSEEPIYIVTEYMSKGSLLDFLKG 105
>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex
pdb|2OMW|A Chain A, Crystal Structure Of Inla S192n Y369s/mec1 Complex
Length = 461
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
T L+ L++ SN +S L LTNL SL N ++ P LG L+ L L LN N
Sbjct: 172 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQ 227
Query: 153 L--MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
L +G + SLTN L LDL+NN+++ P +G
Sbjct: 228 LKDIGTL-ASLTN---LTDLDLANNQISNLAPLSG 258
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 72
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 73 VSEEPIYIVTEYMSKGSLLDFLKG 96
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLL 348
LG G FGKV + D L VAVK LK + +E++++S + H N++
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
L G C L++ + G + + LR
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR 142
>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex
Length = 461
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
T L+ L++ SN +S L LTNL SL N ++ P LG L+ L L LN N
Sbjct: 172 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQ 227
Query: 153 L--MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
L +G + SLTN L LDL+NN+++ P +G
Sbjct: 228 LKDIGTL-ASLTN---LTDLDLANNQISNLAPLSG 258
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 82 VSEEPIYIVIEYMSKGSLLDFLKG 105
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 247
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKG 271
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 82 VSEEPIYIVIEYMSKGSLLDFLKG 105
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 71
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 72 VSEEPIXIVTEYMSKGSLLDFLKG 95
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 42/89 (47%), Gaps = 7/89 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLL 348
LG G FGKV + +D ++ VAVK LK +E++++S + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
L G C L++ + G + + LR
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLR 119
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 82 VSEEPIYIVTEYMSKGSLLDFLKG 105
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 17/62 (27%), Positives = 31/62 (50%), Gaps = 1/62 (1%)
Query: 289 NFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 347
+F LGRGGFG V++ + D A+KR++ + + EV+ ++ H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 348 LR 349
+R
Sbjct: 66 VR 67
>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human)
Recognition Complex
pdb|1O6T|A Chain A, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
pdb|1O6V|A Chain A, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
pdb|1O6V|B Chain B, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
Length = 466
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
T L+ L++ SN +S L LTNL SL N ++ P LG L+ L L LN N
Sbjct: 177 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQ 232
Query: 153 L--MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
L +G + SLTN L LDL+NN+++ P +G
Sbjct: 233 LKDIGTL-ASLTN---LTDLDLANNQISNLAPLSG 263
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 30.4 bits (67), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLL 348
LG G FGKV + D L VAVK LK + +E++++S + H N++
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
L G C L++ + G + + LR
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR 142
>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex
Length = 466
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
T L+ L++ SN +S L LTNL SL N ++ P LG L+ L L LN N
Sbjct: 176 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQ 231
Query: 153 L--MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
L +G + SLTN L LDL+NN+++ P +G
Sbjct: 232 LKDIGTL-ASLTN---LTDLDLANNQISNLAPLSG 262
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 294 NILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ----FQTEVEMISMAVHRNLLR 349
++G+G FG VY G D + ++ + ++ E+Q F E ++ H N+L
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 350 LRGFCMTPTERL--LVYPFMVNGSVASCLR 377
L G M P E L ++ P+M +G + +R
Sbjct: 87 LIGI-MLPPEGLPHVLLPYMCHGDLLQFIR 115
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 42/89 (47%), Gaps = 7/89 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLL 348
LG G FGKV + +D ++ VAVK LK +E++++S + H N++
Sbjct: 49 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
L G C L++ + G + + LR
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLR 137
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 42/89 (47%), Gaps = 7/89 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLL 348
LG G FGKV + +D ++ VAVK LK +E++++S + H N++
Sbjct: 47 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
L G C L++ + G + + LR
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLR 135
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 19/73 (26%), Positives = 40/73 (54%), Gaps = 5/73 (6%)
Query: 285 VATDNFSNRNILGRGGFGKVY--KGRLTDGSLVAVKRL--KEERTQGGELQFQTEVEMIS 340
+ +D + + +LG+G FG+V K ++T G AVK + ++ + + + EV+++
Sbjct: 23 IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 341 MAVHRNLLRLRGF 353
H N+++L F
Sbjct: 82 QLDHPNIMKLYEF 94
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 82 VSEEPIYIVTEYMSKGSLLDFLKG 105
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 30.4 bits (67), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 42/89 (47%), Gaps = 7/89 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLL 348
LG G FGKV + +D ++ VAVK LK +E++++S + H N++
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
L G C L++ + G + + LR
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLR 142
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 21/81 (25%), Positives = 40/81 (49%), Gaps = 11/81 (13%)
Query: 293 RNILGRGGFGKV-----YKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEM--ISMAVHR 345
R LG G FGKV YK + VA+K + + + ++ + E E+ + + H
Sbjct: 14 RETLGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 346 NLLRLRGFCMTPTERLLVYPF 366
++++L TPT+ ++V +
Sbjct: 70 HIIKLYDVITTPTDIVMVIEY 90
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK F E +++ H L++L + +
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNM--SPEAFLQEAQVMKKLRHEKLVQL--YAV 248
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFLKG 272
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 42/89 (47%), Gaps = 7/89 (7%)
Query: 296 LGRGGFGKVYKGRL-----TDGSL-VAVKRLKEERTQGGELQFQTEVEMIS-MAVHRNLL 348
LG G FGKV + +D ++ VAVK LK +E++++S + H N++
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 349 RLRGFCMTPTERLLVYPFMVNGSVASCLR 377
L G C L++ + G + + LR
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLR 142
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 82 VSEEPIYIVCEYMSKGSLLDFLKG 105
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 19/73 (26%), Positives = 40/73 (54%), Gaps = 5/73 (6%)
Query: 285 VATDNFSNRNILGRGGFGKVY--KGRLTDGSLVAVKRL--KEERTQGGELQFQTEVEMIS 340
+ +D + + +LG+G FG+V K ++T G AVK + ++ + + + EV+++
Sbjct: 29 IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 341 MAVHRNLLRLRGF 353
H N+++L F
Sbjct: 88 QLDHPNIMKLYEF 100
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 30.0 bits (66), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 79 VSEEPIYIVTEYMNKGSLLDFLKG 102
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 30.0 bits (66), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 19/31 (61%), Gaps = 1/31 (3%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLTDGSLVAVK 318
DN ++GRG +G VYKG L D VAVK
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVK 42
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 30.0 bits (66), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M GS+ L+G
Sbjct: 79 VSEEPIYIVTEYMNKGSLLDFLKG 102
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 17/103 (16%)
Query: 255 PEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVY--KGRLTDG 312
P DH P F + +D + + +LG+G FG+V K ++T G
Sbjct: 28 PGDHLHATPG------------MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-G 74
Query: 313 SLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
AVK + ++ + + + EV+++ H N+++L F
Sbjct: 75 QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 117
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 17/103 (16%)
Query: 255 PEDHFFDVPAEEDPEVHLGQLKRFSLRELQVATDNFSNRNILGRGGFGKVY--KGRLTDG 312
P DH P F + +D + + +LG+G FG+V K ++T G
Sbjct: 29 PGDHLHATPG------------MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-G 75
Query: 313 SLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 353
AVK + ++ + + + EV+++ H N+++L F
Sbjct: 76 QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 118
>pdb|3UL8|A Chain A, Crystal Structure Of The Tv3 Mutant V134l
Length = 279
Score = 29.6 bits (65), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 24/67 (35%), Positives = 40/67 (59%), Gaps = 6/67 (8%)
Query: 113 LGNLTNLVSLDLYLNNL-NGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVL 170
L +L LV+L+ L +L N PI G L L+ L + +N + ++P +N+ +L+ L
Sbjct: 101 LSSLQKLVALETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 156
Query: 171 DLSNNKL 177
DLS+NK+
Sbjct: 157 DLSSNKI 163
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 29.6 bits (65), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 18/72 (25%), Positives = 38/72 (52%), Gaps = 3/72 (4%)
Query: 281 RELQVATDNFSNRNILGRGGFGKVY--KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEM 338
++ + D + R++LG G F +V + + T LVA+K + ++ +G E + E+ +
Sbjct: 11 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCIAKKALEGKEGSMENEIAV 69
Query: 339 ISMAVHRNLLRL 350
+ H N++ L
Sbjct: 70 LHKIKHPNIVAL 81
>pdb|2Z80|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
pdb|2Z80|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 353
Score = 29.6 bits (65), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 32/107 (29%), Positives = 46/107 (42%), Gaps = 3/107 (2%)
Query: 70 SVTRVDLGNANXXXXXXXXXXXXTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+V +DL N NLQ L L SN I+ + +L +L LDL N L
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 130 NGPIPTTLGKLSKLRFLRL--NNNSLMGEIPRSLTNVNSLQVLDLSN 174
+ + LS L FL L N +GE +++ LQ+L + N
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSL-FSHLTKLQILRVGN 158
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 29.6 bits (65), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 17/64 (26%), Positives = 33/64 (51%), Gaps = 1/64 (1%)
Query: 288 DNFSNRNILGRGGFGKVY-KGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D F + LG G FG V+ + G +K + ++R+Q Q + E+E++ H N
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 347 LLRL 350
++++
Sbjct: 82 IIKI 85
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 29.6 bits (65), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 20/91 (21%), Positives = 38/91 (41%), Gaps = 1/91 (1%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D++ + ++G G V VA+KR+ E+ Q + E++ +S H N
Sbjct: 10 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++ + E LV + GSV ++
Sbjct: 70 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIK 100
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 29.6 bits (65), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 20/91 (21%), Positives = 38/91 (41%), Gaps = 1/91 (1%)
Query: 288 DNFSNRNILGRGGFGKVYKGRLT-DGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
D++ + ++G G V VA+KR+ E+ Q + E++ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
++ + E LV + GSV ++
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIK 105
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 29.6 bits (65), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 37/68 (54%), Gaps = 4/68 (5%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
L+ A+D F +LG+G FG+V K R D A+K+++ T+ +EV +++
Sbjct: 2 LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVXLLAS 58
Query: 342 AVHRNLLR 349
H+ ++R
Sbjct: 59 LNHQYVVR 66
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 29.3 bits (64), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 24/68 (35%), Positives = 33/68 (48%), Gaps = 12/68 (17%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGE----LQFQTEVEM---ISMAVHRN 346
+G G +GKV+K R G VA+KR+ R Q GE L EV + + H N
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 347 LLRLRGFC 354
++RL C
Sbjct: 76 VVRLFDVC 83
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 28.9 bits (63), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 40/84 (47%), Gaps = 6/84 (7%)
Query: 296 LGRGGFGKVYKG-RLTDGSLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRGF 353
LG G +G VYK G +VA+K++ E +LQ E+ ++ ++++ G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 354 CMTPTERLLVYPFMVNGSVASCLR 377
T+ +V + GSV+ +R
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIR 116
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 28.9 bits (63), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 19/71 (26%), Positives = 38/71 (53%), Gaps = 5/71 (7%)
Query: 287 TDNFSNRNILGRGGFGKVY--KGRLTDGSLVAVKRL--KEERTQGGELQFQTEVEMISMA 342
+D + + +LG+G FG+V K ++T G AVK + ++ + + + EV+++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 343 VHRNLLRLRGF 353
H N+ +L F
Sbjct: 84 DHPNIXKLYEF 94
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 28.9 bits (63), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 42/84 (50%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M G + L+G
Sbjct: 82 VSEEPIYIVMEYMSKGCLLDFLKG 105
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 28.9 bits (63), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 37/68 (54%), Gaps = 4/68 (5%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
L+ A+D F +LG+G FG+V K R D A+K+++ T+ +EV +++
Sbjct: 2 LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLAS 58
Query: 342 AVHRNLLR 349
H+ ++R
Sbjct: 59 LNHQYVVR 66
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 28.9 bits (63), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 24/68 (35%), Positives = 33/68 (48%), Gaps = 12/68 (17%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGE----LQFQTEVEM---ISMAVHRN 346
+G G +GKV+K R G VA+KR+ R Q GE L EV + + H N
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 347 LLRLRGFC 354
++RL C
Sbjct: 76 VVRLFDVC 83
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 28.9 bits (63), Expect = 5.5, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 37/68 (54%), Gaps = 4/68 (5%)
Query: 283 LQVATDNFSNRNILGRGGFGKVYKGR-LTDGSLVAVKRLKEERTQGGELQFQTEVEMISM 341
L+ A+D F +LG+G FG+V K R D A+K+++ T+ +EV +++
Sbjct: 2 LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLAS 58
Query: 342 AVHRNLLR 349
H+ ++R
Sbjct: 59 LNHQYVVR 66
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 28.9 bits (63), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 16/36 (44%), Positives = 21/36 (58%), Gaps = 5/36 (13%)
Query: 296 LGRGGFGKVYKGR--LTDGSLVAVKRLKEERTQGGE 329
+G G +GKV+K R G VA+KR+ R Q GE
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGE 51
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 28.9 bits (63), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 31/57 (54%), Gaps = 1/57 (1%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
LG GGFG V + D G VA+K+ ++E + ++ E++++ H N++ R
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain
pdb|2ID5|B Chain B, Crystal Structure Of The Lingo-1 Ectodomain
pdb|2ID5|C Chain C, Crystal Structure Of The Lingo-1 Ectodomain
pdb|2ID5|D Chain D, Crystal Structure Of The Lingo-1 Ectodomain
Length = 477
Score = 28.9 bits (63), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 1/92 (1%)
Query: 94 NLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL 153
NL+ L L SN + L+NL LD+ N + + L L+ L + +N L
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 154 MGEIPRSLTNVNSLQVLDLSNNKLTGDIPTNG 185
+ R+ + +NSL+ L L LT IPT
Sbjct: 141 VYISHRAFSGLNSLEQLTLEKCNLTS-IPTEA 171
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 28.9 bits (63), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 31/57 (54%), Gaps = 1/57 (1%)
Query: 296 LGRGGFGKVYKGRLTD-GSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 351
LG GGFG V + D G VA+K+ ++E + ++ E++++ H N++ R
Sbjct: 23 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 79
>pdb|3ULA|A Chain A, Crystal Structure Of The Tv3 Mutant F63w-Md-2-Eritoran
Complex
pdb|3ULA|C Chain C, Crystal Structure Of The Tv3 Mutant F63w-Md-2-Eritoran
Complex
Length = 279
Score = 28.9 bits (63), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 23/67 (34%), Positives = 40/67 (59%), Gaps = 6/67 (8%)
Query: 113 LGNLTNLVSLDLYLNNL-NGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVL 170
L +L LV+++ L +L N PI G L L+ L + +N + ++P +N+ +L+ L
Sbjct: 101 LSSLQKLVAVETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 156
Query: 171 DLSNNKL 177
DLS+NK+
Sbjct: 157 DLSSNKI 163
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 28.9 bits (63), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 42/84 (50%), Gaps = 5/84 (5%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG+G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 356 TPTERL-LVYPFMVNGSVASCLRG 378
E + +V +M G + L+G
Sbjct: 82 VSEEPIYIVTEYMSKGCLLDFLKG 105
>pdb|3UL7|A Chain A, Crystal Structure Of The Tv3 Mutant F63w
Length = 278
Score = 28.9 bits (63), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 23/67 (34%), Positives = 40/67 (59%), Gaps = 6/67 (8%)
Query: 113 LGNLTNLVSLDLYLNNL-NGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVL 170
L +L LV+++ L +L N PI G L L+ L + +N + ++P +N+ +L+ L
Sbjct: 100 LSSLQKLVAVETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 155
Query: 171 DLSNNKL 177
DLS+NK+
Sbjct: 156 DLSSNKI 162
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 28.9 bits (63), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 9/97 (9%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMIS 340
++ ++ LG G FG+V+ + VAVK +K G + F E ++
Sbjct: 11 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMK 65
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H L++L +T ++ FM GS+ L+
Sbjct: 66 TLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLK 101
>pdb|3UL9|A Chain A, Structure Of The Tv3 Mutant M41e
Length = 278
Score = 28.9 bits (63), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 23/67 (34%), Positives = 40/67 (59%), Gaps = 6/67 (8%)
Query: 113 LGNLTNLVSLDLYLNNL-NGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVL 170
L +L LV+++ L +L N PI G L L+ L + +N + ++P +N+ +L+ L
Sbjct: 100 LSSLQKLVAVETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 155
Query: 171 DLSNNKL 177
DLS+NK+
Sbjct: 156 DLSSNKI 162
>pdb|2Z62|A Chain A, Crystal Structure Of The Tv3 Hybrid Of Human Tlr4 And
Hagfish Vlrb.61
pdb|2Z65|A Chain A, Crystal Structure Of The Human Tlr4 Tv3
Hybrid-Md-2-Eritoran Complex
pdb|2Z65|B Chain B, Crystal Structure Of The Human Tlr4 Tv3
Hybrid-Md-2-Eritoran Complex
Length = 276
Score = 28.9 bits (63), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 23/67 (34%), Positives = 40/67 (59%), Gaps = 6/67 (8%)
Query: 113 LGNLTNLVSLDLYLNNL-NGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVL 170
L +L LV+++ L +L N PI G L L+ L + +N + ++P +N+ +L+ L
Sbjct: 99 LSSLQKLVAVETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 171 DLSNNKL 177
DLS+NK+
Sbjct: 155 DLSSNKI 161
>pdb|2Z7X|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 549
Score = 28.5 bits (62), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 32/107 (29%), Positives = 46/107 (42%), Gaps = 3/107 (2%)
Query: 70 SVTRVDLGNANXXXXXXXXXXXXTNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNL 129
+V +DL N NLQ L L SN I+ + +L +L LDL N L
Sbjct: 27 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 86
Query: 130 NGPIPTTLGKLSKLRFLRL--NNNSLMGEIPRSLTNVNSLQVLDLSN 174
+ + LS L FL L N +GE +++ LQ+L + N
Sbjct: 87 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSL-FSHLTKLQILRVGN 132
>pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein
pdb|2FT3|B Chain B, Crystal Structure Of The Biglycan Dimer Core Protein
pdb|2FT3|C Chain C, Crystal Structure Of The Biglycan Dimer Core Protein
pdb|2FT3|D Chain D, Crystal Structure Of The Biglycan Dimer Core Protein
pdb|2FT3|E Chain E, Crystal Structure Of The Biglycan Dimer Core Protein
pdb|2FT3|F Chain F, Crystal Structure Of The Biglycan Dimer Core Protein
Length = 332
Score = 28.5 bits (62), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 38/84 (45%), Gaps = 1/84 (1%)
Query: 95 LQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSLM 154
L L L N I E+L + L L L N + +L L LR L L+NN L
Sbjct: 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL- 253
Query: 155 GEIPRSLTNVNSLQVLDLSNNKLT 178
+P L ++ LQV+ L N +T
Sbjct: 254 SRVPAGLPDLKLLQVVYLHTNNIT 277
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 28.5 bits (62), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 9/97 (9%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMIS 340
++ ++ LG G FG+V+ + VAVK +K G + F E ++
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAFLAEANVMK 232
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H L++L +T ++ FM GS+ L+
Sbjct: 233 TLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLK 268
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 28.1 bits (61), Expect = 8.6, Method: Compositional matrix adjust.
Identities = 22/91 (24%), Positives = 40/91 (43%), Gaps = 5/91 (5%)
Query: 282 ELQVATDNFSNRNILGRGGFGKVYKGRLTD-GSLVAVKRLK----EERTQGGELQFQTEV 336
+++ + + LG G F VYK R + +VA+K++K E G E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 337 EMISMAVHRNLLRLRGFCMTPTERLLVYPFM 367
+++ H N++ L + LV+ FM
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 28.1 bits (61), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 9/97 (9%)
Query: 284 QVATDNFSNRNILGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQ---FQTEVEMIS 340
++ ++ LG G FG+V+ + VAVK +K G + F E ++
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAFLAEANVMK 238
Query: 341 MAVHRNLLRLRGFCMTPTERLLVYPFMVNGSVASCLR 377
H L++L +T ++ FM GS+ L+
Sbjct: 239 TLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLK 274
>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And
Hagfish Vlrb.61
Length = 570
Score = 28.1 bits (61), Expect = 9.0, Method: Compositional matrix adjust.
Identities = 23/67 (34%), Positives = 40/67 (59%), Gaps = 6/67 (8%)
Query: 113 LGNLTNLVSLDLYLNNL-NGPIPTTLGKLSKLRFLRLNNNSLMG-EIPRSLTNVNSLQVL 170
L +L LV+++ L +L N PI G L L+ L + +N + ++P +N+ +L+ L
Sbjct: 99 LSSLQKLVAVETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 171 DLSNNKL 177
DLS+NK+
Sbjct: 155 DLSSNKI 161
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 28.1 bits (61), Expect = 9.3, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 5/90 (5%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
DNF +G G G V + + G LVAVK++ + Q EL F EV ++ H N
Sbjct: 23 DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHEN 78
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCL 376
++ + + E +V F+ G++ +
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIV 108
>pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte
Receptors B59
pdb|2O6S|B Chain B, Structural Diversity Of The Hagfish Variable Lymphocyte
Receptors B59
Length = 208
Score = 28.1 bits (61), Expect = 9.4, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 36/90 (40%)
Query: 93 TNLQYLELYSNNISGKVPEELGNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNS 152
T+L YL L +N + LT L L L N L KL++L+ LRL N
Sbjct: 76 TSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQ 135
Query: 153 LMGEIPRSLTNVNSLQVLDLSNNKLTGDIP 182
L + SLQ + L +N P
Sbjct: 136 LKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 28.1 bits (61), Expect = 9.7, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 5/90 (5%)
Query: 288 DNFSNRNILGRGGFGKVYKGRL-TDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 346
DNF +G G G V + + G LVAVK++ + Q EL F EV ++ H N
Sbjct: 27 DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHEN 82
Query: 347 LLRLRGFCMTPTERLLVYPFMVNGSVASCL 376
++ + + E +V F+ G++ +
Sbjct: 83 VVEMYNSYLVGDELWVVMEFLEGGALTDIV 112
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 28.1 bits (61), Expect = 9.7, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 41/83 (49%), Gaps = 5/83 (6%)
Query: 296 LGRGGFGKVYKGRLTDGSLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 355
LG G FG+V+ G + VA+K LK T E F E +++ H L++L + +
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLK-PGTMSPE-SFLEEAQIMKKLKHDKLVQL--YAV 72
Query: 356 TPTERL-LVYPFMVNGSVASCLR 377
E + +V +M GS+ L+
Sbjct: 73 VSEEPIYIVTEYMNKGSLLDFLK 95
>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By
Binding Of A Tri-Acylated Lipopeptide
Length = 520
Score = 28.1 bits (61), Expect = 9.8, Method: Compositional matrix adjust.
Identities = 21/69 (30%), Positives = 33/69 (47%), Gaps = 2/69 (2%)
Query: 114 GNLTNLVSLDLYLNNLNGPIPTTLGKLSKLRFLRLNNNSL--MGEIPRSLTNVNSLQVLD 171
++ + LD N L + G L++L L L N L + +I T + SLQ LD
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380
Query: 172 LSNNKLTGD 180
+S N ++ D
Sbjct: 381 ISQNSVSYD 389
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.137 0.407
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 10,277,415
Number of Sequences: 62578
Number of extensions: 370131
Number of successful extensions: 1880
Number of sequences better than 100.0: 604
Number of HSP's better than 100.0 without gapping: 186
Number of HSP's successfully gapped in prelim test: 418
Number of HSP's that attempted gapping in prelim test: 1208
Number of HSP's gapped (non-prelim): 766
length of query: 419
length of database: 14,973,337
effective HSP length: 101
effective length of query: 318
effective length of database: 8,652,959
effective search space: 2751640962
effective search space used: 2751640962
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 53 (25.0 bits)